Processing 00000000.tx.1: Association and Haplotype Analysis of the Insulin-Degrading Enzyme (IDE) Gene, a Strong Positional and Biological Candidate for Type 2 Diabetes Susceptibility Christopher J. 

Phrase: "Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Haplotype Analysis of the Insulin-Degrading Enzyme (IDE) Gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "a Strong Positional"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0240795:POSITIONAL [Finding]
   789 E C0733755:Position [Spatial Concept]

Phrase: "and"

Phrase: "Biological Candidate for Type 2 Diabetes Susceptibility Christopher J."
Processing 00000000.tx.2: Groves1,2, Steven Wiltshire2,3, Damian Smedley3, Katherine R. 

Phrase: "Groves1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Steven Wiltshire2,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Damian Smedley3,"

Phrase: "Katherine R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: Owen4, Timothy M. 

Phrase: "Owen4,"

Phrase: "Timothy M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Frayling4, Mark Walker5, Graham A. 

Phrase: "Frayling4,"

Phrase: "Mark Walker5,"

Phrase: "Graham A."
Processing 00000000.tx.5: Hitman6, Jonathan C. 

Phrase: "Hitman6,"

Phrase: "Jonathan C."
Processing 00000000.tx.6: Levy1, Stephen ORahilly7, Stephan Menzel2, Andrew T. 

Phrase: "Levy1,"

Phrase: "Stephen ORahilly7,"

Phrase: "Stephan Menzel2,"

Phrase: "Andrew T."
Processing 00000000.tx.7: Hattersley4, and Mark I. 

Phrase: "Hattersley4,"

Phrase: "and"

Phrase: "Mark I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.8: McCarthy1,2,3 1 Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, U.K. 

Phrase: "McCarthy1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3 1 Oxford Centre for Diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205099:Center [Spatial Concept]

Phrase: "Endocrinology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   928 E C0694557:endocrinologic [Functional Concept]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Oxford,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.9: 2 Wellcome Trust Centre for Human Genetics, Oxford, U.K. 

Phrase: "2 Wellcome Trust Centre for Human Genetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205099:Center [Spatial Concept]

Phrase: "Oxford,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.10: 3 Genetics and Genomics Research Institute, Imperial College Faculty of Medicine, Hammersmith Hospital, London, U.K. 

Phrase: "3 Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "and"

Phrase: "Genomics Research Institute,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0035172:Research Institute [Organization]
   901   C0887950:Genomics Research [Biomedical Occupation or Discipline]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Imperial College Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015535:Faculty [Professional or Occupational Group]

Phrase: "Hammersmith Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.11: 4 Centre for Molecular Genetics, Peninsular Medical School, Exeter, U.K. 

Phrase: "4 Centre for Molecular Genetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "Peninsular Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Exeter,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.12: 5 School of Clinical Medical Sciences, University of Newcastle, Newcastle, U.K. 

Phrase: "5 School of Clinical Medical Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Newcastle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Newcastle,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.13: 6 Department of Diabetes and Metabolic Medicine, Barts and the London Queen Marys School of Medicine and Dentistry, London, U.K. 

Phrase: "6 Department of Diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Metabolic Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Barts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979852:Barts [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "the London Queen Marys School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Dentistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011438:Dentistry [Biomedical Occupation or Discipline]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.14: 7 Departments of Medicine and Clinical Biochemistry, Addenbrookes Hospital, Cambridge, U.K.  

Phrase: "7 Departments of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Clinical Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "Addenbrookes Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Cambridge,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.15: ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS REFERENCES  The gene for insulin-degrading enzyme (IDE) represents a strong positional and biological candidate for type 2 diabetes susceptibility. 

Phrase: "ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The gene for insulin-degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1333402:Enzyme Gene [Gene or Genome]
   783   C1337112:Insulin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a strong positional"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0240795:POSITIONAL [Finding]
   789 E C0733755:Position [Spatial Concept]

Phrase: "and"

Phrase: "biological candidate for type 2 diabetes susceptibility."
Processing 00000000.tx.16: IDE maps to chromosome 10q23.3, a region linked to diabetes in several populations; 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "maps to chromosome 10q23.3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0008666:Chromosome 3 [Cell Component]
   797   C0814036:chromosome map [Intellectual Product]
   760   C0008633:Chromosome [Cell Component]
   760   C0024779:Map [Manufactured Object]
   760   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1706473:Map [Conceptual Entity]

Phrase: "a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "linked to diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "in several populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: ";"
Processing 00000000.tx.17: the rat homolog has been directly implicated in diabetes susceptibility; 

Phrase: "the rat homolog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1334043:Homolog [Gene or Genome]
   761 E C2697616:Homology [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "implicated in diabetes susceptibility"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.18: and known functions of IDE support an important role in glucose homeostasis. 

Phrase: "and"

Phrase: "known functions of IDE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "an important role in glucose homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.19: We sought evidence for association between IDE variation and diabetes by mutation screening, defining local haplotype structure, and genotyping variants delineating common haplotypic diversity. 

Phrase: "We"

Phrase: "sought"

Phrase: "evidence for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "between IDE variation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205419:Variation [Qualitative Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "and"

Phrase: "diabetes by mutation screening,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0199229:diabetes screening [Diagnostic Procedure]
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: "defining"

Phrase: "local haplotype structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "genotyping variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "delineating"

Phrase: "common haplotypic diversity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880371:Diversity [Qualitative Concept]
Processing 00000000.tx.20: An initial case-control analysis (628 diabetic probands from multiplex sibships and 604 control subjects) found no haplotypic associations, although one variant (IDE2, -179TC) showed modest association with diabetes (odds ratio [OR]1.25, P = 0.03). 

Phrase: "An initial case-control analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "(628 diabetic probands from multiplex sibships"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0702111:probands [Organism Attribute]
   719 E C1948021:Proband [Family Group]

Phrase: "and"

Phrase: "604 control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no haplotypic associations,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "although"

Phrase: "one variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "(IDE2, -"

Phrase: "179TC"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "modest association with diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "(odds ratio [OR]1.25,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.21: Linkage partitioning analyses failed to support this association, but provided borderline evidence for a different variant (IDE10, IVS20405AG) (P = 0.06). 

Phrase: "Linkage partitioning analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0796345:linkage analysis [Laboratory Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "but"

Phrase: "provided borderline evidence for a different variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence [Functional Concept]

Phrase: "(IDE10,"

Phrase: "IVS20405AG"

Phrase: ")"

Phrase: "(P = 0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.22: Neither variant was associated with diabetes when replication was sought in 377 early onset diabetic subjects and 825 control subjects, though combined analysis of all typed cohorts indicated a nominally significant effect at IDE2 (OR 1.21 [1.041.40], P = 0.013). 

Phrase: "Neither variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variant [Qualitative Concept]

Phrase: "was"

Phrase: "associated with diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "when"

Phrase: "replication"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0598312:Replication [Genetic Function]
  1000   C1883725:replication [Qualitative Concept]
   928 E C0205173:Replicate [Functional Concept]
   928 E C0205341:Replicate [Functional Concept]

Phrase: "was"

Phrase: "sought in 377 early onset diabetic subjects"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1833334:Early-onset [Finding]
   748   C0241863:DIABETIC [Finding]
   748   C0332162:Onset [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "825 control subjects,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "though"

Phrase: "combined analysis of all typed cohorts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0086027:Analysis, Cohort [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "a nominally significant effect at IDE2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(OR 1.21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "[1.041.40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439509:/40 [Temporal Concept]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "],"

Phrase: "P = 0.013"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.23: In the absence of convincing support for this association from linkage partitioning or analyses of continuous measures of glycemia, we conclude that analysis of over 2,400 samples provides no compelling evidence that variation in IDE contributes to diabetes susceptibility in humans. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of convincing support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183683:Support [Medical Device]
   861   C1521721:Support [Conceptual Entity]

Phrase: "for this association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "from linkage partitioning"

Phrase: "or"

Phrase: "analyses of continuous measures of glycemia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that analysis of over 2,400 samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1303103:Sample analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "no compelling evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that variation in IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "contributes to diabetes susceptibility"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   770   C1880177:Contribute [Activity]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.24: Linkage disequilibrium analysis within candidate genes represents the final common pathway for the identification of diabetes-susceptibility genes. 

Phrase: "Linkage disequilibrium analysis within candidate genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   809   C2717880:Candidate Gene Analysis [Molecular Biology Research Technique]
   783   C0796345:analysis linkage [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the final common pathway for the identification of diabetes-susceptibility genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1704259:Pathway [Molecular Function]
   738   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.25: Candidate selection is typically based on positional information from linkage studies in humans and rodent models and/or a perceived match between the genes function and the pathophysiology of the condition. 

Phrase: "Candidate selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: "is"

Phrase: "typically"

Phrase: "based on positional information"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0240795:POSITIONAL [Finding]
   770   C1527178:Based [Functional Concept]
   770   C1533716:Information [Idea or Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "studies in humans"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0178693:humans studies [Research Activity]
   790   C0086418:Humans [Human]
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "rodent models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "and/or"

Phrase: "a perceived match between the genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150103:match [Research Activity]
   753   C1708943:Match [Qualitative Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "the pathophysiology of the condition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031847:pathophysiology [Functional Concept]
   760   C0277785:Pathophysiology [Qualitative Concept]
Processing 00000000.tx.26: Several independent lines of evidence suggest a role for the gene encoding the insulin-degrading enzyme (IDE: LOCUSLINK reference 3416; 

Phrase: "Several independent lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205132:lines [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for the gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "LOCUSLINK reference 3416"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514811:Reference [Idea or Concept]
   827   C1706462:Reference [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.27: EC reference 3.4.24.56) in type 2 diabetes pathogenesis, making this a promising candidate for analysis. 

Phrase: "EC reference 3.4.24.56"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1514811:Reference [Idea or Concept]
   799   C1706462:Reference [Conceptual Entity]

Phrase: ")"

Phrase: "in type 2 diabetes pathogenesis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0543483:pathogenesis [Functional Concept]
   812   C0699748:Pathogenesis [Pathologic Function]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   708   C1320657:type diabetes [Finding]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "this a promising candidate for analysis."
Processing 00000000.tx.28: First, IDE maps to a region, on chromosome 10q, showing evidence for linkage to type 2 diabetes in several populations. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "maps to a region,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017446:Region [Geographic Area]
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205147:Region [Spatial Concept]
   770   C1706473:Map [Conceptual Entity]

Phrase: "on chromosome 10q,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520266:10q [Nucleotide Sequence]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "to type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in several populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.29: In a genomewide scan of 573 U.K. type 2 diabetic pedigrees, evidence for linkage (multipoint logarithm of odds [LOD] = 1.99) peaked near to D10S1765, only 4 Mb from IDE, and conditional analyses have suggested epistatic interaction with the well-replicated susceptibility locus on chromosome 1q (1). 

Phrase: "In a genomewide scan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034606:Scan [Diagnostic Procedure]
   861   C0441633:Scan [Diagnostic Procedure]
   861   C2826292:SCAN [Finding]

Phrase: "of 573 U.K. type 2 diabetic pedigrees,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0030761:pedigrees [Intellectual Product]

Phrase: "evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "(multipoint logarithm of odds [LOD]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986775:Logarithm [Occupational Activity]

Phrase: "= 1.99"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "peaked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaked [Quantitative Concept]

Phrase: "near to D10S1765,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0205107:Near to [Spatial Concept]
   882   C1706276:Near to [Qualitative Concept]
           Near
   790   C0475806:Near [Finding]

Phrase: "only 4 Mb from IDE,"

Phrase: "and"

Phrase: "conditional analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "suggested epistatic interaction with the well-replicated susceptibility locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "on chromosome 1q"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327882:chromosome 1q [Nucleotide Sequence]
           1q

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.30: Linkage to 10q has also been reported in Finns (2), North American Europeans (3), Mexican Americans (4), and French (5), though the latter two map 4050 cM telomeric and may reflect a distinct locus. 

Phrase: "Linkage to 10q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023745:linkage [Molecular Function]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported in Finns"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0337803:Finns [Population Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "North American Europeans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0239307:European [Population Group]
   793   C1535514:European [Population Group]
   734   C0425358:NORTH AMERICAN [Finding]
   734   C2700615:North American [Population Group]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "Mexican Americans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025884:Mexican Americans [Population Group]
   861   C0596070:americans [Population Group]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "French"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "though"

Phrase: "the latter two map 4050 cM"

Phrase: "telomeric"

Phrase: "and"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a distinct locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.31: Second, the rat homolog of IDE is directly implicated in type 2 diabetes susceptibility. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the rat homolog of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1334043:Homolog [Gene or Genome]

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "implicated in type 2 diabetes susceptibility."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0011860:Type 2 Diabetes [Disease or Syndrome]
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]
   753   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.32: In the GK rat model (6,7), a locus for poststimulation glycemia was mapped to a region of rat chromosome 1 syntenic with human 10q23-26 (8,9) and subsequently localized to a 1-cM region around Ide (10). 

Phrase: "In the GK rat model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "a locus for poststimulation glycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "was"

Phrase: "mapped to a region of rat chromosome 1 syntenic"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   784   C1953345:Region of chromosome [Cell]
           Chromosome region
   764   C0008651:Chromosome 1 [Cell Component]
   762   C1514732:Rat-1 [Cell]
   745   C0814036:chromosome map [Intellectual Product]
   745   C1424473:MAP-1 [Gene or Genome]
   742   C0008633:Chromosome [Cell Component]
   742   C0017446:Region [Geographic Area]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0205147:Region [Spatial Concept]
   708   C0024779:Map [Manufactured Object]
   708   C1706473:Map [Conceptual Entity]

Phrase: "with human 10q23-26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086418:Human [Human]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: "and"

Phrase: "subsequently"

Phrase: "localized to a 1-cM region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0392752:Localized [Spatial Concept]

Phrase: "around Ide (10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0328104:Ide [Fish]
   861   C1415875:IDE [Gene or Genome]
   861   C2826366:IDE [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.33: Two amino-acid substitutions in Ide were found in susceptible congenic strains, which, together, conferred postprandial hyperglycemia and reduced insulin degradation in isolated muscle cells, and other diabetes-related phenotypes (10). 

Phrase: "Two amino-acid substitutions in Ide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   719   C1555721:Substitution [Idea or Concept]
   719   C1706204:Substitution [Activity]

Phrase: "were"

Phrase: "found in susceptible congenic strains,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1516786:Congenic Strain [Animal]
   760   C0080194:Strains [Injury or Poisoning]
   760   C0150312:Found [Quantitative Concept]
   760   C0231204:Susceptible [Functional Concept]
   760   C0456178:strains [Intellectual Product]
   760   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   726 E C0243095:Find [Finding]
   726 E C1518614:Strain [Organism]
   726 E C2987481:Strain [Mental Process]

Phrase: "which,"

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "conferred"

Phrase: "postprandial hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1855520:Hyperglycemia, Postprandial [Finding]
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "reduced insulin degradation in isolated muscle cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "other diabetes-related phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.34: Third, the known and presumed functions of IDE are consistent with a role in type 2 diabetes pathogenesis. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "the known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "and"

Phrase: "presumed functions of IDE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "consistent with a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in type 2 diabetes pathogenesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0543483:pathogenesis [Functional Concept]
   812   C0699748:Pathogenesis [Pathologic Function]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   708   C1320657:type diabetes [Finding]
Processing 00000000.tx.35: IDE, a 110 kDa Zn2+-regulated metalloproteinase, displays a wide expression profile including all insulin-responsive tissues. 

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a 110 kDa Zn2+-regulated metalloproteinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a wide expression profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "all insulin-responsive tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.36: Strong species conservation attests to important biological functions, and diverse cellular and metabolic roles have been proposed (11,12). 

Phrase: "Strong species conservation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347858:Conservation [Qualitative Concept]

Phrase: "attests to important biological functions,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   773   C0031845:Biological function, NOS [Physiologic Function]
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205460:biological [Qualitative Concept]
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "diverse cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007634:Cellular [Cell]
   861   C0178539:Cellular [Functional Concept]
   789 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "metabolic roles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035820:Roles [Social Behavior]
   827 E C1705810:Role [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.37: Although some of these remain controversial (13), IDE seems to play a major role in the breakdown of insulin in insulin-responsive tissues (14), thereby influencing the extent of the cellular response to insulin (11). 

Phrase: "Although"

Phrase: "some of these"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "remain"

Phrase: "controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a major role in the breakdown of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in insulin-responsive tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "influencing"

Phrase: "the extent of the cellular response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.38: This association between IDE activity and insulin clearance and resistance is supported by in vitro and clinical studies (1416). 

Phrase: "This association between IDE activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "insulin clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0237834:Resistance [Mental Process]
  1000   C1514892:Resistance [Physiologic Function]
   928 E C0332325:Resistant [Functional Concept]
   928 E C1550464:resistent [Idea or Concept]
   928 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "is"

Phrase: "supported by in vitro"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "clinical studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0008972:Clinical Studies [Research Activity]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(1416"

Phrase: ")."
Processing 00000000.tx.39: Furthermore, the substrate specificity of IDE coincides with peptides capable of amyloid formation (including both amylin and insulin), indicating that IDE may prevent accumulation of amyloidogenic peptides (12). 

Phrase: "Furthermore,"

Phrase: "the substrate specificity of IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0038592:Substrate Specificity [Quantitative Concept]
   774   C0178623:enzyme substrate [Chemical Viewed Functionally]
   774   C0678612:enzyme specificity [Natural Phenomenon or Process]
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]
   748   C1710236:Substrate [Manufactured Object]

Phrase: "coincides with peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "capable of amyloid formation"

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "both amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "accumulation of amyloidogenic peptides"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.40: Disruption of this scavenging function might thereby promote aggregation of the islet amyloid characteristic of type 2 diabetes and contribute to deficient -cell capacity. 

Phrase: "Disruption of this scavenging function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "might"

Phrase: "thereby"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "aggregation of the islet amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "characteristic of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C3645613:Characteristic type [Intellectual Product]
   760   C1521970:Characteristic [Qualitative Concept]

Phrase: "and"

Phrase: "contribute to deficient -cell capacity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007634:Cell [Cell]
   760   C0011155:Deficient [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1516240:Capacity [Quantitative Concept]
   760   C1636779:% deficient [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1880177:Contribute [Activity]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.41: This congruence of positional and biological candicacy led us to evaluate the role of IDE variation in diabetes susceptibility in humans. 

Phrase: "This congruence of positional"

Phrase: "and"

Phrase: "biological candicacy"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the role of IDE variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in diabetes susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0012655:Susceptibility [Clinical Attribute]
   861   C0220898:Susceptibility [Organism Attribute]
   861   C1264642:Susceptibility [Functional Concept]
   861   C1547045:*Susceptibility [Quantitative Concept]
   789 E C0231204:Susceptible [Functional Concept]
   789 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.42: Mutation screening of all exons, adjacent intronic sequence, and 600 bp of 5' sequence in probands from 10q-linked pedigrees identified six confirmed variants (Table 1 and Fig. 1). 

Phrase: "Mutation screening of all exons,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]

Phrase: "adjacent intronic sequence,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "600 bp of 5' sequence"

Phrase: "in probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "from 10q-linked pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030761:pedigrees [Intellectual Product]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "six confirmed variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.43: For convenience, these are termed IDE single nucleotide polymorphisms (SNPs) 2, 3, 4, 5, 8, and 9 in accordance with previous nomenclature (17). 

Phrase: "For convenience,"

Phrase: "these"

Phrase: "are"

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "IDE single nucleotide polymorphisms (SNPs) 2,"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0032529:polymorphisms [Genetic Function]
   795   C0037179:Single [Population Group]
   795   C0087136:single [Finding]
   795   C0205171:Single [Quantitative Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   762 E C1882417:Polymorphism [Qualitative Concept]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "8,"

Phrase: "and"

Phrase: "9 in accordance with previous nomenclature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205156:Previous [Temporal Concept]
   753   C0600281:Nomenclature [Intellectual Product]
   753   C1524067:Nomenclature [Intellectual Product]
   753   C1552607:previous [Temporal Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.44: We did not detect the uncommon IDE6 and IDE7 variants previously reported (17), and IDE1 and IDE10 mapped outside the sequence surveyed. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the uncommon IDE6"

Phrase: "and"

Phrase: "IDE7 variants previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "IDE1"

Phrase: "and"

Phrase: "IDE10"

Phrase: "mapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0024779:Map [Manufactured Object]
   966   C1706473:Map [Conceptual Entity]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "surveyed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0038951:Survey [Intellectual Product]
Processing 00000000.tx.45: None of the variants appeared to have strong functional credentials based on sequence context. 

Phrase: "None of the variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205419:variants [Qualitative Concept]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "strong functional credentials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010298:credentials [Governmental or Regulatory Activity]
   827   C2362313:Credentials [Intellectual Product]

Phrase: "based on sequence context."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   802   C0004793:Base Sequence [Nucleotide Sequence]
           Sequence
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0449255:Context [Finding]
   770   C0542559:Context [Functional Concept]
   770   C1519249:Sequence [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.46: A putative nonsynonymous exon 15 coding polymorphism reported in dbSNP (rs2229708) was not validated on sequencing or direct genotyping. 

Phrase: "A putative nonsynonymous exon 15 coding polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]

Phrase: "reported in dbSNP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1710090:dbSNP [Intellectual Product]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(rs2229708"

Phrase: ")"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "validated on sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]

Phrase: "or"

Phrase: "direct genotyping."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.47: Analysis of 348 European Collection of Cell Cultures (ECACC) control samples confirmed extensive linkage disequilibrium across the gene (all pairwise D' values >0.60, Fig. 

Phrase: "Analysis of 348 European Collection of Cell Cultures (ECACC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "extensive linkage disequilibrium across the gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   753   C0023745:linkage [Molecular Function]
   753   C0281825:Disequilibrium [Finding]
   753   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "("

Phrase: "all pairwise D' values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: ">0.60,"

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.48: 1). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.49: Six common haplotypes (HAP1 to HAP6) were identified, accounting for >97% of all chromosomes (Fig. 1). 

Phrase: "Six common haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "(HAP1 to HAP6"

Phrase: ")"

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "accounting for"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C0000938:Accounting [Occupational Activity]
   799 E C1551359:account [Idea or Concept]
   799 E C2741673:Account # [Clinical Attribute]
   799 E C2981730:Account [Classification]

Phrase: ">97% of all chromosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008633:Chromosomes [Cell Component]
   770   C0439073:97 [Intellectual Product]
   770   C0439082:>97 [Quantitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.50: On the basis of allele frequencies (IDE5, IDE6, and IDE7: each <5%) and intermarker linkage disequilibrium patterns (IDE3 concordant with IDE1), SNPs 1, 2, 4, 8, 9, and 10 were selected for further genotyping. 

Phrase: "On the basis of allele frequencies"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0017270:Frequencies, Allele [Quantitative Concept]
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "(IDE5,"

Phrase: "IDE6,"

Phrase: "and"

Phrase: "IDE7"

Phrase: ":"

Phrase: "each"

Phrase: "<5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "intermarker linkage disequilibrium patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Patterns [Spatial Concept]

Phrase: "(IDE3"

Phrase: "concordant with IDE1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0680240:concordance [Social Behavior]

Phrase: ")"

Phrase: ","

Phrase: "SNPs 1,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "8,"

Phrase: "9,"

Phrase: "and"

Phrase: "10"

Phrase: "were"

Phrase: "selected for further genotyping."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1285573:Genotyping [Laboratory Procedure]
   770   C1517331:Further [Spatial Concept]
   737 E C0205108:far [Spatial Concept]
   737   C1707391:Select [Activity]
Processing 00000000.tx.51: View this table: [in this window] [in a new window]  TABLE 1 IDE variants relevant to this study  View larger version (52K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 IDE variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205419:variants [Qualitative Concept]

Phrase: "relevant to this study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.52: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.53: Genomic position, linkage disequilibrium relationships, and haplotype frequencies of variants within the IDE gene. 

Phrase: "Genomic position,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "linkage disequilibrium relationships,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439849:Relationships [Qualitative Concept]
   793 E C1705630:Relationship [Idea or Concept]
   793 E C1706279:Relationship [Idea or Concept]
   793 E C3540605:Relationship [Intellectual Product]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "and"

Phrase: "haplotype frequencies of variants"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "within the IDE gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1337112:Insulin Gene [Gene or Genome]
   861   C1333402:Enzyme Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
Processing 00000000.tx.54: The depiction of the IDE gene displays the exon distribution (not to scale, see distances provided above) and genomic location of the SNPs examined in this study. 

Phrase: "The depiction of the IDE gene"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "the exon distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "("

Phrase: "not to scale,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0175659:Scale [Medical Device]
   790   C0349674:Scale [Intellectual Product]
   790   C1518422:Not [Functional Concept]
   790   C1947916:Scale [Activity]
   790   C3536777:Scale [Manufactured Object]
   718 E C1710017:Scalar [Qualitative Concept]
   706 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "distances"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:distances [Quantitative Concept]
   916 E C0443203:Distant [Spatial Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "genomic location of the SNPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0450429:Location [Spatial Concept]
   748   C1515974:Location [Body Location or Region]

Phrase: "examined in this study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332128:Examined [Finding]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.55: The middle panel details linkage disequilibrium parameters (D' above the diagonal, P value below), calculated in 348 random U.K. samples (the ECACC sample) for the six SNPs genotyped. 

Phrase: "The middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "details"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522508:Detail [Qualitative Concept]
  1000   C1561567:detail [Functional Concept]

Phrase: "linkage disequilibrium parameters"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0449381:Parameters [Finding]
   793 E C0549193:Parameter [Spatial Concept]
   793 E C1704769:Parameter [Conceptual Entity]
   793 E C2350001:Parameter [Quantitative Concept]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "("

Phrase: "D' above the diagonal, P value"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1709380:P-Value [Quantitative Concept]
   783   C1512024:D.P. [Intellectual Product]
   753   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0443198:Diagonal [Spatial Concept]
   753   C1522609:Value [Quantitative Concept]

Phrase: "below"

Phrase: ")"

Phrase: ","

Phrase: "calculated in 348 random U.K. samples"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   757   C0150105:random sample [Research Activity]
   748   C0034656:RANDOM [Research Activity]
   748   C0439605:Random [Qualitative Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1708601:K' [Quantitative Concept]
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: "the ECACC sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   788   C0598080:cell culture collection [Intellectual Product]
   774   C0200345:collection sample [Laboratory Procedure]
   748   C1516698:Collection [Functional Concept]
   748   C1704814:Collection [Idea or Concept]

Phrase: ")"

Phrase: "for the six SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "genotyped."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.56: The lower panel lists the ten most frequent haplotypes estimated from the typed data sets and their frequencies in the CON1 control subjects (made up of the ECACC and DIF samples) and the W2P case set.  

Phrase: "The lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0745732:List [Conceptual Entity]
  1000   C3272378:LIST [Intellectual Product]

Phrase: "the ten most frequent haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "estimated from the typed data sets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0150098:data sets [Intellectual Product]
   753   C0036849:Set [Mental Process]
   753   C0750572:Estimated [Quantitative Concept]
   753   C1442518:Set [Functional Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "their frequencies in the CON1 control subjects"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   748   C0439603:Frequencies [Temporal Concept]
   714 E C0376249:frequency [Quantitative Concept]
   714 E C0871396:Frequency [Quantitative Concept]
   714 E C1561548:Frequency [Qualitative Concept]
   714 E C1705502:Frequency [Quantitative Concept]

Phrase: "(made up of the ECACC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1881534:Make [Functional Concept]

Phrase: "and"

Phrase: "DIF samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]

Phrase: ")"

Phrase: "and"

Phrase: "the W2P case set."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0036849:Set [Mental Process]
   804   C1442518:Set [Functional Concept]
   804   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.57: All SNPs were in Hardy-Weinberg equilibrium in all data sets, except for IDE4 (P = 0.01) and IDE9 (P = 0.04), in the Diabetes in Families Study (DIF) control sample only. 

Phrase: "All SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were in Hardy-Weinberg equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]

Phrase: "in all data sets,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0150098:data sets [Intellectual Product]
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1511726:Data [Idea or Concept]
   861   C1705195:Set [Conceptual Entity]
   861   C3245479:data [Medical Device]

Phrase: "except for IDE4"

Phrase: "(P = 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "IDE9"

Phrase: "(P = 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "in the Diabetes in Families Study (DIF)"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   827   C0199236:Family study, NOS [Diagnostic Procedure]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0011849:Diabetes [Disease or Syndrome]
   799   C0015576:Families [Family Group]
   799   C0150312:In [Quantitative Concept]
   799   C0332285:In [Spatial Concept]
   799   C0557651:Study [Manufactured Object]
   799   C1704727:Family [Conceptual Entity]
   799   C2603343:Study [Research Activity]
   716 E C0241888:Familial [Functional Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "only."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]
Processing 00000000.tx.58: These samples were retyped with 100% concordance, and haplotype patterns provided no indication of mistyping (no novel haplotypes were generated). 

Phrase: "These samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "retyped with 100% concordance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680240:concordance [Social Behavior]

Phrase: "and"

Phrase: "haplotype patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Patterns [Spatial Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "no indication of mistyping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0521090:No indication of [Qualitative Concept]
   770   C0392360:indication [Idea or Concept]
   770   C3146298:Indication [Functional Concept]

Phrase: "("

Phrase: "no novel haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ")."
Processing 00000000.tx.59: These modest departures from equilibrium are likely, therefore, to reflect stochastic variation and are not exceptional given the number of tests performed. 

Phrase: "These modest departures from equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1555578:departure [Idea or Concept]
   726   C1706081:Departure [Activity]

Phrase: "are"

Phrase: "likely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "therefore,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "stochastic variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "not exceptional given"

Phrase: "the number of tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.60: Allele and genotype frequencies for the Warren 2 proband (W2P) cases (n = 628) and control group (CON1) subjects (n = 604) are shown in Table 2 (see RESEARCH DESIGN AND METHODS for group characteristics). 

Phrase: "Allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "genotype frequencies for the Warren 2 proband (W2P) cases"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   744   C0439603:Frequencies [Temporal Concept]
   711 E C0376249:frequency [Quantitative Concept]
   711 E C0871396:Frequency [Quantitative Concept]
   711 E C1561548:Frequency [Qualitative Concept]
   711 E C1705502:Frequency [Quantitative Concept]

Phrase: "(n = 628"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(CON1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418867:CON1 [Gene or Genome]

Phrase: ")"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "(n = 604"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown in Table 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS for group characteristics"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.61: The only nominally significant association detected was between W2P and CON1 samples at IDE2 (genotypes P = 0.045; alleles P = 0.030; odds ratio [OR] for C allele 1.25 [95% CI 1.021.52]). 

Phrase: "The only nominally significant association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0004083:Association [Mental Process]
   812   C0439849:Association [Qualitative Concept]
   812   C0596306:Association [Phenomenon or Process]
   812   C0699792:association [Social Behavior]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "was between W2P"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1948021:Proband [Family Group]
   704 E C0702110:Propositus [Organism Attribute]

Phrase: "and"

Phrase: "CON1 samples at IDE2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "(genotypes P = 0.045"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "; alleles P = 0.030"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "; odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "[OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "]"

Phrase: "for C allele 1.25"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1418485:C-1 [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   812   C1553033:[c] [Quantitative Concept]

Phrase: "[95% CI 1.021.52"

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.62: There was no global difference in haplotype frequency distribution (Fig. 1) between the groups (P = 0.33). 

Phrase: "There"

Phrase: "was"

Phrase: "no global difference in haplotype frequency distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "between the groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "(P = 0.33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.63: However, since HAP2 is defined by the C allele at IDE2, this haplotype was also more frequent in probands than CON1 control subjects (P = 0.03, uncorrected). 

Phrase: "However,"

Phrase: "since"

Phrase: "HAP2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1415470:HAP2 [Gene or Genome]
  1000   C1417715:HAP2 [Gene or Genome]
  1000   C3540480:HAP2 [Gene or Genome]

Phrase: "is"

Phrase: "defined by the C allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "at IDE2,"

Phrase: "this haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "was"

Phrase: "also more frequent in probands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332183:Frequent [Temporal Concept]

Phrase: "than CON1 control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(P = 0.03,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "uncorrected"

Phrase: ")."
Processing 00000000.tx.64: Males and females did not differ in SNP or haplotype frequencies, and no additional associations were uncovered by sex-stratified analyses. 

Phrase: "Males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ in SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0752046:SNP [Nucleotide Sequence]
   790   C1527094:SNP [Conceptual Entity]

Phrase: "or"

Phrase: "haplotype frequencies,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "no additional associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "uncovered by sex-stratified analyses."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0009253:Sex [Organism Function]
   760   C0036864:Sex [Behavior]
   760   C0079399:sex [Organism Attribute]
   760   C0205363:Stratified [Qualitative Concept]
   760   C0439845:Uncovered [Functional Concept]
   760   C1314687:Sex [Finding]
   760   C1522384:sex [Organism Attribute]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
Processing 00000000.tx.65: View this table: [in this window] [in a new window]  TABLE 2 Genotype and allele frequencies at IDE haplotype-tag (ht) SNPs  To determine whether associations might be more evident in families with apparent 10q linkage, we subdivided the W2P sample according to the family nonparametric linkage (NPL) score at the 10q locus. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "allele frequencies at IDE haplotype-tag (ht) SNPs  To"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   753   C0017270:Frequencies, Allele [Quantitative Concept]
   736   C0439603:Frequencies [Temporal Concept]
   703 E C0376249:frequency [Quantitative Concept]
   703 E C0871396:Frequency [Quantitative Concept]
   703 E C1561548:Frequency [Qualitative Concept]
   703 E C1705502:Frequency [Quantitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0004083:Associations [Mental Process]
   966 E C0439849:Association [Qualitative Concept]
   966 E C0596306:Association [Phenomenon or Process]
   966 E C0699792:association [Social Behavior]

Phrase: "might"

Phrase: "be"

Phrase: "more evident in families"

Phrase: "with apparent 10q linkage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023745:linkage [Molecular Function]

Phrase: "we"

Phrase: "subdivided"

Phrase: "the W2P sample according to the family nonparametric linkage (NPL) score"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0370003:Sample [Substance]
   736   C2347026:Sample [Conceptual Entity]

Phrase: "at the 10q locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.66: Such linkage partitioning methods have been applied in several recent type 2 diabetes studies (1821). 

Phrase: "Such linkage partitioning methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "applied in several recent type 2 diabetes studies"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   770   C0441730:Type 2 [Classification]
   767   C1320657:Diabetes type [Finding]
   750   C0035171:Study Type [Research Activity]
   750   C2985227:Study Type [Research Activity]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0185125:Applied [Health Care Activity]
   744   C0332185:Recent [Temporal Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0947630:studies [Laboratory Procedure]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0557651:Study [Manufactured Object]
   711 E C1632850:Apply [Functional Concept]
   711 E C1879355:Apply [Functional Concept]
   711 E C2603343:Study [Research Activity]

Phrase: "(1821"

Phrase: ")."
Processing 00000000.tx.67: Here, we used linkage partitioning in a purely exploratory capacity, given uncertainties over the statistical properties of these methods when the evidence for linkage is not confirmed, as well as the possible consequences of partitioning bias when stratifying on proband genotype alone. 

Phrase: "Here,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "linkage partitioning in a purely exploratory capacity,"

Phrase: "given uncertainties over the statistical properties of these methods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0087130:uncertainties [Idea or Concept]

Phrase: "when"

Phrase: "the evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: ","

Phrase: "as well as"

Phrase: "the possible consequences of partitioning bias"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "when"

Phrase: "stratifying on proband genotype"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017431:Genotype [Organism Attribute]
   770   C0205363:stratifying [Qualitative Concept]
   770   C1948021:Proband [Family Group]
   715 E C0702110:Propositus [Organism Attribute]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.68: No difference was evident between "linked" and "unlinked" probands in IDE haplotype frequencies (P = 0.86), IDE2 genotypes (P = 0.61), or IDE10 genotypes (P = 0.18). 

Phrase: "No difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "evident between """
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C0332120:Evidence [Functional Concept]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: """"

Phrase: "and """

Phrase: "unlinked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1548448:UNLINK [Intellectual Product]

Phrase: """ probands in IDE haplotype frequencies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0702111:probands [Organism Attribute]
   714 E C1948021:Proband [Family Group]

Phrase: "(P = 0.86"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "IDE2 genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "(P = 0.61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "IDE10 genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "(P = 0.18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.69: The association previously seen at IDE2, between W2P and CON1, was attenuated when only linked probands were considered (genotypes P = 0.10; alleles P = 0.08). 

Phrase: "The association previously"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "seen at IDE2,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "between W2P"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1948021:Proband [Family Group]
   771 E C0702110:Propositus [Organism Attribute]
   743 E C0702111:probands [Organism Attribute]

Phrase: "and"

Phrase: "CON1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418867:CON1 [Gene or Genome]

Phrase: "was"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "when"

Phrase: "only linked probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0702111:probands [Organism Attribute]
   793 E C1948021:Proband [Family Group]
   755 E C0702110:Propositus [Organism Attribute]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "(genotypes P = 0.10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "; alleles P = 0.08"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.70: There was no difference in IDE10 genotype frequencies between 10q-linked probands and CON1 control subjects (P = 0.34). 

Phrase: "There"

Phrase: "was"

Phrase: "no difference in IDE10 genotype frequencies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between 10q-linked probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0702111:probands [Organism Attribute]
   793 E C1948021:Proband [Family Group]
   755 E C0702110:Propositus [Organism Attribute]

Phrase: "and"

Phrase: "CON1 control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(P = 0.34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.71: However, the complementary analysis, testing whether IDE genotype partitioned the evidence for 10q linkage, was more encouraging. 

Phrase: "However,"

Phrase: "the complementary analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "testing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]

Phrase: "whether"

Phrase: "IDE genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0017431:Genotype [Organism Attribute]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "partitioned"

Phrase: "the evidence for 10q linkage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "was"

Phrase: "more encouraging."
Processing 00000000.tx.72: In families in which the proband carried the weakly associated IDE2 genotypes, CT and CC, the LOD score at D10S1765 increased from 1.72 to 1.96 (P = 0.09 for the increment). 

Phrase: "In families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "in which"

Phrase: "the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "the weakly associated IDE2 genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538933:CC [Cell Component]

Phrase: "the LOD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986775:Logarithm [Occupational Activity]

Phrase: "score at D10S1765"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449820:Score [Quantitative Concept]

Phrase: "increased from 1.72"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "to 1.96"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(P = 0.09 for the increment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1705117:Increment [Quantitative Concept]
   753   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.73: The same analysis based on IDE10 genotype (grouping GA and GG), yielded a LOD of 2.12 (P = 0.06). 

Phrase: "The same analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "based on IDE10 genotype"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0017431:Genotype [Organism Attribute]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(grouping GA"

Phrase: "and"

Phrase: "GG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018370:GG [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "yielded"

Phrase: "a LOD of 2.12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986775:Logarithm [Occupational Activity]

Phrase: "(P = 0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.74: Clarification of the role of IDE2 and IDE10 variants was sought by further genotyping in early-onset type 2 diabetic cases (YT2D, Warren 2 trios [W2T]) and a large control resource (CON2). 

Phrase: "Clarification of the role of IDE2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1266845:Role clarification [Therapeutic or Preventive Procedure]
   753   C2986669:Clarification [Activity]

Phrase: "and"

Phrase: "IDE10 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "was"

Phrase: "sought by further genotyping"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1285573:Genotyping [Laboratory Procedure]
   770   C1517331:Further [Spatial Concept]
   737 E C0205108:far [Spatial Concept]

Phrase: "in early-onset type 2 diabetic cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]

Phrase: "(YT2D,"

Phrase: "Warren 2 trios [W2T]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1336674:TRIO [Gene or Genome]
   793   C1448979:TRIO [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "a large control resource"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035201:Resource [Idea or Concept]

Phrase: "(CON2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418866:CON2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.75: Both young-onset case groups had similar clinical characteristics (Table 3), and genotypes were combined after appropriate tests of homogeneity. 

Phrase: "Both young-onset case groups"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C0868928:Case [Functional Concept]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]

Phrase: "had"

Phrase: "similar clinical characteristics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683325:clinical characteristics [Clinical Attribute]
   827   C1521970:Characteristics [Qualitative Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "combined after appropriate tests of homogeneity."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0022885:Tests [Laboratory Procedure]
   753   C0205195:Combined [Qualitative Concept]
   753   C0392366:Tests [Intellectual Product]
   753   C1548787:Appropriate [Qualitative Concept]
   753   C1881065:Homogeneity [Qualitative Concept]
   719 E C0039593:Test [Functional Concept]
   719 E C0336789:Combine [Manufactured Object]
Processing 00000000.tx.76: These replication cohorts have an average age-at-diagnosis some 15 years earlier than the sibpair probands; 

Phrase: "These replication cohorts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:cohorts [Population Group]

Phrase: "have"

Phrase: "an average age-at-diagnosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1828181:Age at diagnosis [Clinical Attribute]
   812   C0011900:Diagnosis [Finding]
   812   C1704338:diagnosis [Qualitative Concept]
   812   C1704656:DIAGNOSIS [Research Activity]

Phrase: "some 15 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "earlier than the sibpair probands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1279919:Early [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.77: however, both rigorous exclusion of non-type 2 diabetes and the high parental prevalence of typical late-onset type 2 diabetes in both cohorts (22,23) argue against appreciable qualitative differences in the genetic basis of type 2 diabetes susceptibility between the initial and replication cohorts. 

Phrase: "however,"

Phrase: "both rigorous exclusion of non-type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0680251:EXCLUSION [Functional Concept]
   744   C2828389:Exclusion [Activity]

Phrase: "and"

Phrase: "the high parental prevalence of typical late-onset type 2 diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1512456:High Prevalence [Quantitative Concept]
   738   C0033105:Prevalence [Quantitative Concept]
   738   C0220900:prevalence [Quantitative Concept]

Phrase: "in both cohorts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599755:cohorts [Population Group]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "argue against appreciable qualitative differences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205556:Qualitative [Qualitative Concept]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in the genetic basis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "of type 2 diabetes susceptibility"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0012655:Susceptibility [Clinical Attribute]
   812   C0220898:Susceptibility [Organism Attribute]
   812   C1264642:Susceptibility [Functional Concept]
   812   C1547045:*Susceptibility [Quantitative Concept]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   741 E C0231204:Susceptible [Functional Concept]
   741 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   708   C1320657:type diabetes [Finding]

Phrase: "between the initial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205265:Initial [Temporal Concept]
  1000   C1279901:Initial [Qualitative Concept]
  1000   C1555582:Initial [Idea or Concept]
  1000   C1705685:INITIAL [Functional Concept]

Phrase: "and"

Phrase: "replication cohorts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:cohorts [Population Group]
Processing 00000000.tx.78: Typing IDE2 and IDE10 effectively reduces IDE haplotypic diversity to three common haplotypes (Fig. 1). 

Phrase: "Typing IDE2"

Phrase: "and"

Phrase: "IDE10 effectively"

Phrase: "reduces"

Phrase: "IDE haplotypic diversity to three common haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880371:Diversity [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.79: Genotype and allele counts are shown in Table 2. 

Phrase: "Genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "allele counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439157:counts [Quantitative Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]

Phrase: "are"

Phrase: "shown in Table 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.80: All data were in Hardy-Weinberg equilibrium. 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were in Hardy-Weinberg equilibrium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]
Processing 00000000.tx.81: In these replication cohorts, we found no significant association of either SNP (IDE2: genotypes P = 0.14, alleles P = 0.17, OR for C allele 1.17[0.941.45]; 

Phrase: "In these replication cohorts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:cohorts [Population Group]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant association of either SNP (IDE2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: ":"

Phrase: "genotypes P = 0.14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "alleles P = 0.17,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "OR for C allele 1.17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0028873:Odds Ratio [Quantitative Concept]
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "[0.941.45"

Phrase: "]"

Phrase: ";"
Processing 00000000.tx.82: IDE10: P > 0.80) or the 2-10 haplotype (P = 0.41), regardless of whether the data were stratified for sex. 

Phrase: "IDE10"

Phrase: ":"

Phrase: "P > 0.80"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "the 2-10 haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotype [Organism Attribute]

Phrase: "(P = 0.41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "regardless of"

Phrase: "whether"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "stratified for sex."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0009253:Sex [Organism Function]
   790   C0036864:Sex [Behavior]
   790   C0079399:sex [Organism Attribute]
   790   C0205363:Stratified [Qualitative Concept]
   790   C1314687:Sex [Finding]
   790   C1522384:sex [Organism Attribute]
Processing 00000000.tx.83: In the full Exeter Family Study (EFS) cohort (n = 841), there was no association between either SNP and fasting plasma glucose on combined or sex-stratified analyses. 

Phrase: "In the full Exeter Family Study (EFS) cohort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0599755:Cohort [Population Group]

Phrase: "(n = 841"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "no association between either SNP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "fasting plasma glucose on combined"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0202042:Plasma glucose [Laboratory Procedure]
   806   C0455280:plasma glucose [Laboratory or Test Result]
   760   C0015663:Fasting [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0032105:Plasma [Body Substance]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1550565:fasting [Intellectual Product]
   726 E C0456962:Fast [Qualitative Concept]

Phrase: "or"

Phrase: "sex-stratified analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
Processing 00000000.tx.84: View this table: [in this window] [in a new window]  TABLE 3 Clinical characteristics of the populations studied  Having selected IDE on the basis of its positional and biological candidacy as a type 2 diabetes susceptibility gene, and undertaken a detailed survey of variation within the gene, we have been unable to compile any clear evidence for association between IDE variation and type 2 diabetes. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3 Clinical characteristics of the populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0683325:clinical characteristics [Clinical Attribute]
   774   C0032661:Population Characteristics [Group Attribute]
   748   C1521970:Characteristics [Qualitative Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "Having"

Phrase: "selected IDE on the basis of its positional"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "biological candidacy as a type 2 diabetes susceptibility gene,"

Phrase: "and"

Phrase: "undertaken"

Phrase: "a detailed survey of variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0038951:Survey [Intellectual Product]

Phrase: "within the gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "we"

Phrase: "have"

Phrase: "been"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "compile"

Phrase: "any clear evidence for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "between IDE variation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205419:Variation [Qualitative Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.85: This, despite the fact that our analyses utilized several large and well-characterized populations, and selection of the diabetic individualsfor early onset and positive family historywas designed to enhance detection of type 2 diabetes susceptibility alleles. 

Phrase: "This,"

Phrase: "despite the fact"

Phrase: "that"

Phrase: "our analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "utilized"

Phrase: "several large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "well-characterized populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "selection of the diabetic individualsfor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036576:selection [Genetic Function]

Phrase: "early onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1833334:Early-onset [Finding]
   861   C0332162:Onset [Qualitative Concept]
   861   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "positive family historywas"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "detection of type 2 diabetes susceptibility alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.86: The only SNP showing association in the initial case-control analysis (IDE2) was not associated in our replication set. 

Phrase: "The only SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0752046:SNP [Nucleotide Sequence]
   861   C1527094:SNP [Conceptual Entity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "association in the initial case-control analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "(IDE2"

Phrase: ")"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated in our replication set."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0036849:Set [Mental Process]
   760   C0332281:Associated [Qualitative Concept]
   760   C0598312:Replication [Genetic Function]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
   760   C1883725:replication [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.87: However, it is worth noting that the combined OR for IDE2 across both initial and replication sets does achieve nominal significance (combined OR for allele C, 1.21 [1.041.40], P = 0.013). 

Phrase: "However,"

Phrase: "it"

Phrase: "is worth noting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the combined OR for IDE2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "across both initial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205265:Initial [Temporal Concept]
  1000   C1279901:Initial [Qualitative Concept]
  1000   C1555582:Initial [Idea or Concept]
  1000   C1705685:INITIAL [Functional Concept]

Phrase: "and"

Phrase: "replication sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "does"

Phrase: "achieve"

Phrase: "nominal significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0237881:Significance [Quantitative Concept]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "(combined OR for allele C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "1.21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[1.041.40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439509:/40 [Temporal Concept]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "],"

Phrase: "P = 0.013"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.88: This result demands cautious interpretation, given allowance for the low (though unquantifiable) prior odds that even strong biological candidates, such as IDE, will harbor substantial susceptibility effects and for the lack of support from any of the other analyses performed. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "demands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441516:Demand [Therapeutic or Preventive Procedure]
  1000   C0699784:demand [Idea or Concept]

Phrase: "cautious interpretation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0459471:Interpretation [Intellectual Product]
   861   C3173575:Interpretation [Clinical Attribute]

Phrase: "given allowance for the low"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0556660:Allowance [Quantitative Concept]
   760   C1524004:Allowance [Intellectual Product]

Phrase: "("

Phrase: "though"

Phrase: "unquantifiable"

Phrase: ")"

Phrase: "prior odds"

Phrase: "that even strong biological candidates,"

Phrase: "such as IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "will"

Phrase: "harbor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "substantial susceptibility effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "and for the lack of support"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0183683:Support [Medical Device]
   753   C0332268:lack [Qualitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C1521721:Support [Conceptual Entity]

Phrase: "from any"

Phrase: "of the"

Phrase: "other analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.89: The only other variant emerging from the initial analyses, IDE10, showed some ability to partition the evidence for linkage, but showed no evidence of association with type 2 diabetes (combined OR for allele A, 1.01 [0.871.17], P = 0.91). 

Phrase: "The only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "other variant emerging from the initial analyses,"

Phrase: "IDE10,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "some ability to partition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "the evidence for linkage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "but"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(combined OR for allele A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "1.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[0.871.17"

Phrase: "],"

Phrase: "P = 0.91"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.90: Our survey of IDE variation covered all exons, adjacent intronic sequence, and the promoter. 

Phrase: "Our survey of IDE variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0038951:Survey [Intellectual Product]

Phrase: "covered"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439844:Covered [Functional Concept]
  1000   C1999244:Covered [Functional Concept]
   966 E C0180153:cover [Medical Device]
   966 E C1707529:Cover [Medical Device]

Phrase: "all exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "adjacent intronic sequence,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "the promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.91: None of the variants identified in this, or an earlier screen of U.K. subjects (17), has strong credentials for an impact on IDE structure and/or function. 

Phrase: "None of the variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205419:variants [Qualitative Concept]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "identified in this,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "or"

Phrase: "an earlier screen of U.K. subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220908:screen [Health Care Activity]
   748   C1305399:screen [Functional Concept]
   748   C1705053:Screen [Medical Device]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "has"

Phrase: "strong credentials for an impact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0010298:credentials [Governmental or Regulatory Activity]
   760   C2362313:Credentials [Intellectual Product]

Phrase: "on IDE structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0596527:enzyme structure [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0678594:Structure [Spatial Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "and/or"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.92: Clearly, our findings do not support the hypothesis that variation within IDE is exclusively responsible for the linkage signal detected on chromosome 10q. 

Phrase: "Clearly,"

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that variation within IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "exclusively responsible for the linkage signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "detected on chromosome 10q."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008633:Chromosome [Cell Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1520266:10q [Nucleotide Sequence]
Processing 00000000.tx.93: However, as with any association study, we cannot exclude the possibility that the variants typed (especially IDE2) have a lesser susceptibility role. 

Phrase: "However,"

Phrase: "as with any association study,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   760   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "typed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332307:Type [Qualitative Concept]
   966   C1547052:*Type [Quantitative Concept]

Phrase: "(especially IDE2"

Phrase: ")"

Phrase: "have"

Phrase: "a lesser susceptibility role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.94: The present study has, we estimate, >95% power to detect an association between IDE2 and type 2 diabetes under a multiplicative model with a genotypic relative risk of 1.2, at a threshold P value of 0.05. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: ","

Phrase: "we"

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: ","

Phrase: ">95% power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "an association between IDE2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "type 2 diabetes under a multiplicative model"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0011860:Type 2 Diabetes [Disease or Syndrome]
   778   C0441730:Type 2 [Classification]
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "with a genotypic relative risk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0242492:Relative Risk [Quantitative Concept]
   827   C0017431:Genotypic [Organism Attribute]
   827   C0035647:Risk [Qualitative Concept]
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "of 1.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "at a threshold P value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "of 0.05."
Processing 00000000.tx.95: This falls to 60% under a more stringent significance threshold (P = 0.001) designed to reflect modest prior odds that the candidate selected plays a biologically significant susceptibility role. 

Phrase: "This falls to 60%"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0085639:Falls [Finding]
   737 E C0238715:Fall [Temporal Concept]

Phrase: "under a more stringent significance threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449864:Threshold [Qualitative Concept]

Phrase: "(P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "modest prior odds"

Phrase: "that"

Phrase: "the candidate"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a biologically significant susceptibility role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0035820:Role [Social Behavior]
   812   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.96: Furthermore, we cannot entirely exclude the possibility that IDE variants other than those studied have a more marked contribution to type 2 diabetes susceptibility. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "cannot"

Phrase: "entirely"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that IDE variants other than those studied"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:variants [Qualitative Concept]

Phrase: "have"

Phrase: "a more marked contribution to type 2 diabetes susceptibility."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880177:Contribution [Activity]
Processing 00000000.tx.97: If so, such variants must lie outside the regions surveyed and display limited linkage disequilibrium with any of the typed variants. 

Phrase: "If"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "such variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "must"

Phrase: "lie"

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "surveyed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0038951:Survey [Intellectual Product]

Phrase: "and"

Phrase: "display limited linkage disequilibrium with any of the typed variants."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0023746:Linkage Disequilibrium [Quantitative Concept]
   739   C0023745:linkage [Molecular Function]
   739   C0281825:Disequilibrium [Finding]
   739   C0394006:Disequilibrium [Disease or Syndrome]
Processing 00000000.tx.98: Current understanding of linkage disequilibrium patterns within human populations indicates that analyses, such as ours, which seek associations using SNPs capturing haplotypic diversity within the gene of interest, will have good power to detect associations with other, as yet unidentified, common variants within the same gene (24).  

Phrase: "Current understanding of linkage disequilibrium patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162340:Understanding [Mental Process]

Phrase: "within human populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "indicates"

Phrase: "that analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "such as ours,"

Phrase: "which"

Phrase: "seek"

Phrase: "associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0004083:Associations [Mental Process]
   966 E C0439849:Association [Qualitative Concept]
   966 E C0596306:Association [Phenomenon or Process]
   966 E C0699792:association [Social Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "capturing"

Phrase: "haplotypic diversity within the gene of interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880371:Diversity [Qualitative Concept]

Phrase: "will"

Phrase: "have"

Phrase: "good power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "associations with other,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0004083:Associations [Mental Process]
   756 E C0439849:Association [Qualitative Concept]
   756 E C0596306:Association [Phenomenon or Process]
   756 E C0699792:association [Social Behavior]

Phrase: "as yet unidentified, common variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "within the same gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.99: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS REFERENCES  Subjects: Clinical characteristics of the cohorts studied are provided in Table 3. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: ":"

Phrase: "Clinical characteristics of the cohorts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0683325:clinical characteristics [Clinical Attribute]
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "provided in Table 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.100: Initial case-control analyses compared unrelated index probands (n = 628) from the Diabetes U.K. 

Phrase: "Initial case-control analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "unrelated index probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0702111:probands [Organism Attribute]
   793 E C1948021:Proband [Family Group]
   755 E C0702110:Propositus [Organism Attribute]

Phrase: "(n = 628"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "from the Diabetes U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.101: Warren 2 sibpair repository ("W2P") (1) with control samples from two sources: 1) 348 random U.K. population samples (from CAMR, Salisbury, U.K.) 

Phrase: "Warren 2 sibpair repository"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0872261:Repository [Manufactured Object]

Phrase: "(""W2P"""
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1948021:Proband [Family Group]
   771 E C0702110:Propositus [Organism Attribute]
   743 E C0702111:probands [Organism Attribute]

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "with control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "from two sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449416:sources [Finding]
   827 E C1705919:Source [Idea or Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "348 random U.K. population samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   859   C0150105:random sample [Research Activity]
   766   C0370003:Sample [Substance]
   766   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: "from CAMR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1825528:CAMR [Gene or Genome]
  1000   C1846168:CAMR [Disease or Syndrome]

Phrase: "Salisbury,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"
Processing 00000000.tx.102: ("ECACC") and 2) 256 U.K. subjects ascertained for the Diabetes in Families study ("DIF"). 

Phrase: "(""ECACC"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0598080:cell culture collection [Intellectual Product]
   760   C1516698:Collection [Functional Concept]
   760   C1704814:Collection [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "256 U.K. subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "ascertained for the Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in Families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(""DIF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0199236:Family study, NOS [Diagnostic Procedure]
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0015576:Families [Family Group]
   770   C0557651:Study [Manufactured Object]
   770   C1704727:Family [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: """"

Phrase: ")."
Processing 00000000.tx.103: All subjects in the latter were normoglycemic (fasting glucose <6.0mmol/l) and without family history of diabetes. 

Phrase: "All"

Phrase: "subjects in the latter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "normoglycemic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580545:Normoglycaemic [Finding]

Phrase: "(fasting glucose"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0015663:Fasting [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1550565:fasting [Intellectual Product]
   827 E C0456962:Fast [Qualitative Concept]

Phrase: "<6.0mmol/l)"

Phrase: "and without family history of diabetes."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0241889:Family history [Finding]
   790   C1705495:Family History [Idea or Concept]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0015576:Family [Family Group]
   753   C0019664:History [Occupation or Discipline]
   753   C0019665:history [Intellectual Product]
   753   C0262512:History, NOS [Organism Attribute]
   753   C0262926:History [Finding]
   753   C1515981:And [Idea or Concept]
   753   C1704727:Family [Conceptual Entity]
   753   C1705255:History [Conceptual Entity]
   753   C2004062:History [Finding]
Processing 00000000.tx.104: When combined, these control samples are designated "CON1." 

Phrase: "When"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: ","

Phrase: "these control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "are"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: """CON1."""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418867:CON1 [Gene or Genome]
Processing 00000000.tx.105: Replication analyses combined two collections of young-onset type 2 diabetes subjects with similar clinical characteristics: 1) offspring from parent-offspring trios (n = 142) ascertained for type 2 diabetes ("W2T") (22) and 2) young-onset (<45 years) type 2 diabetic subjects (n = 235) ("YT2D") (23). 

Phrase: "Replication analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "two collections of young-onset type 2 diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   789   C0445613:Type of collection [Intellectual Product]
   744   C0600644:Collections [Intellectual Product]
   744   C1516698:Collection [Functional Concept]
   744   C1704814:Collection [Idea or Concept]

Phrase: "subjects with similar clinical characteristics"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0683325:clinical characteristics [Clinical Attribute]
   797   C0681884:subject characteristics [Research Activity]
   797   C1519021:Subject Characteristics [Organism Attribute]
   797   C1706465:Subject Characteristics [Idea or Concept]
   760   C0205210:Clinical [Qualitative Concept]
   760   C0681850:Subject [Group]
   760   C1521970:Characteristics [Qualitative Concept]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2348205:Similar [Qualitative Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "offspring from parent-offspring trios"

Phrase: "(n = 142"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "ascertained for type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(""W2T"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1336674:TRIO [Gene or Genome]
   793   C1448979:TRIO [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "young-onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332162:Onset [Qualitative Concept]

Phrase: "("

Phrase: "<45 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "type 2 diabetic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "(n = 235"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(""YT2D"""

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.106: These cases were compared with 841 unrelated parents from a consecutive birth cohort (the EFS), 825 of whom were normoglycemic ("CON2") (23). 

Phrase: "These cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "compared with 841 unrelated parents"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0030551:Parents [Family Group]
   760   C0445356:Unrelated [Finding]
   760   C1704623:Unrelated [Qualitative Concept]
   760   C1707455:Compared [Activity]
   726 E C2699423:Parent [Conceptual Entity]

Phrase: "from a consecutive birth cohort"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1706962:Birth Cohort [Quantitative Concept]
   827   C0599755:Cohort [Population Group]

Phrase: "("

Phrase: "the EFS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0199236:Family study, NOS [Diagnostic Procedure]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "825 of whom"

Phrase: "were"

Phrase: "normoglycemic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580545:Normoglycaemic [Finding]

Phrase: "(""CON2"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418866:CON2 [Gene or Genome]

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.107: All case samples are therefore selected for inherited type 2 diabetes via early onset and/or positive family history. 

Phrase: "All case samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "are"

Phrase: "therefore"

Phrase: "selected for inherited type 2 diabetes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0011860:Type 2 Diabetes [Disease or Syndrome]
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C0439660:Inherited [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   719   C1707391:Select [Activity]

Phrase: "via early onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1833334:Early-onset [Finding]
   861   C0332162:Onset [Qualitative Concept]
   861   C1279919:Early [Temporal Concept]

Phrase: "and/or"

Phrase: "positive family history."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   901   C0241889:Family history [Finding]
   901   C1705495:Family History [Idea or Concept]
   827   C0015576:Family [Family Group]
   827   C0019664:History [Occupation or Discipline]
   827   C0019665:history [Intellectual Product]
   827   C0262512:History, NOS [Organism Attribute]
   827   C0262926:History [Finding]
   827   C1704727:Family [Conceptual Entity]
   827   C1705255:History [Conceptual Entity]
   827   C2004062:History [Finding]
   755 E C0241888:Familial [Functional Concept]
   755 E C1552658:Historical [Idea or Concept]
   755 E C1552723:Historical [Idea or Concept]
Processing 00000000.tx.108: Non-type 2 diabetes was excluded using a combination of clinical, immunological, and genetic criteria (1,22). 

Phrase: "Non-type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a combination of clinical, immunological,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "genetic criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.109: Confirmation of glycemic status in the control populations was limited to fasting plasma glucose measures for the DIF and EFS samples. 

Phrase: "Confirmation of glycemic status"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   770   C0750484:Confirmation [Idea or Concept]

Phrase: "in the control populations"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C0032662:control population [Occupation or Discipline]
   861   C0032659:Population [Quantitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1257890:Population [Population Group]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "limited to fasting plasma glucose"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0202042:Plasma glucose [Laboratory Procedure]
   806   C0455280:plasma glucose [Laboratory or Test Result]
   760   C0015663:Fasting [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0032105:Plasma [Body Substance]
   760   C0439801:Limited [Functional Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1550565:fasting [Intellectual Product]
   760   C3542948:Limited [Intellectual Product]
   726 E C0456962:Fast [Qualitative Concept]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]

Phrase: "measures for the DIF"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0199236:Family study, NOS [Diagnostic Procedure]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0015576:Families [Family Group]
   748   C0079809:Measure [Quantitative Concept]
   748   C0242485:Measure [Functional Concept]
   748   C0557651:Study [Manufactured Object]
   748   C1704727:Family [Conceptual Entity]
   748   C1879489:Measures [Functional Concept]
   748   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "EFS samples."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0199236:Family study, NOS [Diagnostic Procedure]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.110: All subjects are of exclusively British/Irish Caucasian origin (except for a small proportion with non-British but European ancestry in the W2T set). 

Phrase: "All subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "are of exclusively British/Irish Caucasian origin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0007457:Caucasian [Population Group]
   748   C0043157:Caucasian [Population Group]
   748   C0079946:origin [Classification]
   748   C0087186:Irish [Population Group]
   748   C0439659:Origin [Temporal Concept]
   748   C0596227:British [Population Group]
   748   C1550512:origin [Intellectual Product]
   748   C1551058:Are [Quantitative Concept]

Phrase: "("

Phrase: "except for a small proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1709707:Proportion [Quantitative Concept]
   789 E C0205351:Proportional [Qualitative Concept]

Phrase: "with non-British"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596227:British [Population Group]

Phrase: "but"

Phrase: "European ancestry in the W2T set"

Phrase: ")."
Processing 00000000.tx.111: Gene structure and mutation detection. 

Phrase: "Gene structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517495:Gene Structure [Gene or Genome]
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "mutation detection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513778:Mutation Detection [Laboratory Procedure]
   861   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.112: The genomic structure of IDE was determined through BLAST alignment of human mRNA sequence (M21188) with the finished genomic sequence of BAC clone AL356128. 

Phrase: "The genomic structure of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0596527:enzyme structure [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0678594:Structure [Spatial Concept]

Phrase: "was"

Phrase: "determined through BLAST alignment of human mRNA sequence"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086418:Human [Human]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0337026:Blast [Natural Phenomenon or Process]
   744   C0368761:blast [Cell]
   744   C1519249:Sequence [Functional Concept]
   744   C1706765:Alignment [Quantitative Concept]

Phrase: "(M21188"

Phrase: ")"

Phrase: "with the finished genomic sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "of BAC clone AL356128."
Processing 00000000.tx.113: This confirmed IDE as having 25 exons distributed between positions 93.09 and 93.22 Mb on the NCBI30 assembly of chromosome 10. 

Phrase: "This confirmed IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "having"

Phrase: "25 exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "distributed between positions 93.09"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0733755:positions [Spatial Concept]
   760   C1704711:Distributed [Functional Concept]

Phrase: "and"

Phrase: "93.22 Mb on the NCBI30 assembly of chromosome 10."
Processing 00000000.tx.114: Variant detection was performed by direct sequencing in both directions (Big Dye Terminator chemistry; Perkin Elmer Applied Biosystems, Warrington, U.K.) on an ABI3700 capillary sequencer. 

Phrase: "Variant detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed by direct sequencing"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0439851:Direct [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   770   C1947931:Direct [Qualitative Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in both directions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0439755:Directions [Spatial Concept]
   966 E C0449738:Direction [Spatial Concept]
   893 E C1707761:Directionality [Functional Concept]
   893 E C3274524:Directionality [Functional Concept]

Phrase: "(Big Dye Terminator chemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007996:Chemistry [Occupation or Discipline]
   812   C0079107:chemistry [Classification]
   812   C0201682:Chemistry [Laboratory Procedure]

Phrase: "; Perkin Elmer Applied Biosystems,"

Phrase: "Warrington,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "on an ABI3700 capillary sequencer."
Processing 00000000.tx.115: We included all exons, >50 bp of flanking introns, and 600 bp of 5' untranslated region (UTR) in 27 amplicons. 

Phrase: "We"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "all exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ">50 bp of flanking introns,"

Phrase: "and"

Phrase: "600 bp of 5' untranslated region (UTR)"

Phrase: "in 27 amplicons."
Processing 00000000.tx.116: Primer sequences are provided in online Table 1 (http://diabetes.diabetesjournals.org). 

Phrase: "Primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "provided in online Table 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0039224:Table [Manufactured Object]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   760   C1999230:Provided [Activity]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//diabetes.diabetesjournals.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.117: In total, 11 individuals were sequenced. 

Phrase: "In total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "11 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "were"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.118: Eight were type 2 diabetic probands from sibships where all affected were identical-by-descent on both chromosomes at flanking microsatellites (D10S1765, D10S185). 

Phrase: "Eight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205454:Eight [Quantitative Concept]

Phrase: "were"

Phrase: "type 2 diabetic probands from sibships where"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0702111:probands [Organism Attribute]
   714 E C1948021:Proband [Family Group]

Phrase: "all"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "were"

Phrase: "identical-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]

Phrase: "by-descent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680043:descent [Family Group]

Phrase: "on both chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosomes [Cell Component]

Phrase: "at flanking microsatellites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519302:Microsatellites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(D10S1765,"

Phrase: "D10S185"

Phrase: ")."
Processing 00000000.tx.119: Because such probands, assuming 10q linkage, are enriched for 10q susceptibility variants, we estimate >90% power to detect disease-associated variants (assuming multiplicative models and genotype relative risk of 1.5) for allele frequencies >8.7%. 

Phrase: "Because"

Phrase: "such probands,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "assuming"

Phrase: "10q linkage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023745:linkage [Molecular Function]

Phrase: "are"

Phrase: "enriched for 10q susceptibility variants,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0205419:variants [Qualitative Concept]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C0359583:enriched [Food]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1520266:10q [Nucleotide Sequence]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "we"

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: ">90% power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "disease-associated variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "("

Phrase: "assuming"

Phrase: "multiplicative models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "genotype relative risk of 1.5"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0242492:Relative Risk [Quantitative Concept]
   783   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0035647:Risk [Qualitative Concept]
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: ")"

Phrase: "for allele frequencies"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0017270:Frequencies, Allele [Quantitative Concept]
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: ">8.7%."
Processing 00000000.tx.120: The other three were unaffected siblings from the same families, doubly discordant for 10q haplotypes covering IDE, when compared with their affected sibs. 

Phrase: "The"

Phrase: "other three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "were"

Phrase: "unaffected siblings from the same families,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0037047:Siblings [Family Group]
   719 E C1611273:Sibling [Intellectual Product]

Phrase: "doubly discordant for 10q haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3639994:Discordant [Conceptual Entity]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "when"

Phrase: "compared with their affected sibs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1707455:Compared [Activity]
   726   C0037047:Sib [Family Group]
Processing 00000000.tx.121: SNP genotyping. 

Phrase: "SNP genotyping."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.122: Selected IDE SNPs were genotyped using a combination of approaches including restriction fragment-length polymorphism detection, artificial induced restriction sites, and tetra-primer amplification refractory mutation methods. 

Phrase: "Selected IDE SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   845   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   795   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0032529:polymorphisms [Genetic Function]
   795   C0037179:Single [Population Group]
   795   C0087136:single [Finding]
   795   C0205171:Single [Quantitative Concept]
   762 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a combination of approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "restriction fragment-length polymorphism detection,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0796451:Polymorphism Detection [Diagnostic Procedure]
   804   C1511790:Detection [Therapeutic or Preventive Procedure]
   771   C0035268:Restriction fragment length polymorphism [Clinical Attribute]

Phrase: "artificial induced restriction sites,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0443288:Restriction [Functional Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "tetra-primer amplification refractory mutation methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0025663:Methods [Intellectual Product]
   799   C0025664:methods [Intellectual Product]
   799   C0449851:Methods [Functional Concept]
   766 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.123: Assays of the first two types included obligate restriction sites as internal digest controls. 

Phrase: "Assays of the first two types"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "obligate"

Phrase: "restriction sites as internal digest controls."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   756   C1882940:Restriction Site [Nucleotide Sequence]
   753   C0205145:Sites [Spatial Concept]
   753   C0443288:Restriction [Functional Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.124: For assay details, see online Table 2 (http://diabetes.diabetesjournals.org). 

Phrase: "For assay details,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1522508:Details [Qualitative Concept]
   827 E C1561567:detail [Functional Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "online Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039224:Table [Manufactured Object]
   827   C1706073:Table [Medical Device]
   827   C1706074:Table [Intellectual Product]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//diabetes.diabetesjournals.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.125: Statistical methods. 

Phrase: "Statistical methods."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C1710191:Statistical Method [Research Activity]
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.126: Genotype and allele frequency distributions were compared by standard contingency table methods with exact probability estimation, using STATXACT (Cytel, Cambridge, MA). 

Phrase: "Genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "allele frequency distributions"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0017270:Allele Frequency [Quantitative Concept]
   867   C0237580:Frequency Distribution [Quantitative Concept]
   827   C0037775:Distributions [Spatial Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   793 E C0520511:distribution [Idea or Concept]
   793 E C1704711:Distribution [Functional Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "compared by standard contingency table methods"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0039224:Table [Manufactured Object]
   753   C0449851:Methods [Functional Concept]
   753   C1442989:Standard [Qualitative Concept]
   753   C1701901:Contingency [Qualitative Concept]
   753   C1706073:Table [Medical Device]
   753   C1706074:Table [Intellectual Product]
   753   C1707455:Compared [Activity]
   753   C2828392:Standard [Intellectual Product]
   719 E C0871511:METHOD [Intellectual Product]

Phrase: "with exact probability estimation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0680844:estimation [Mental Process]
   827   C0681916:Estimation [Quantitative Concept]
   827   C0750572:Estimation [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "STATXACT"

Phrase: "(Cytel,"

Phrase: "Cambridge,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.127: Genotype comparisons used the Kruskal-Wallis statistic given the ordinal categorization. 

Phrase: "Genotype comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Kruskal-Wallis statistic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C2348149:Statistic [Quantitative Concept]
   827   C2828391:Statistic [Quantitative Concept]
   755 E C0038215:Statistical [Occupation or Discipline]

Phrase: "given"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]

Phrase: "the ordinal categorization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008902:categorization [Classification]
Processing 00000000.tx.128: Separate data sets (e.g., the W2T and YT2D sets) were combined for contingency table analyses only after appropriate homogeneity testing. 

Phrase: "Separate data sets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0150098:data sets [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "the W2T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1336674:TRIO [Gene or Genome]
   793   C1448979:TRIO [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "YT2D sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: ")"

Phrase: "were"

Phrase: "combined for contingency table analyses only"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C0039224:Table [Manufactured Object]
   753   C0205171:Only [Quantitative Concept]
   753   C0205195:Combined [Qualitative Concept]
   753   C1701901:Contingency [Qualitative Concept]
   753   C1706073:Table [Medical Device]
   753   C1706074:Table [Intellectual Product]
   753   C1720467:Only [Intellectual Product]
   719   C0002778:Analysis [Laboratory Procedure]
   719 E C0336789:Combine [Manufactured Object]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "after appropriate homogeneity testing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039593:Testing [Functional Concept]
   827   C0392366:testing [Intellectual Product]
Processing 00000000.tx.129: Haplotype patterns were estimated by maximum-likelihood methods (SNPHAP, www-gene.cimr.cam.ac.uk/clayton/software/) and haplotype frequency distributions compared by likelihood-ratio testing. 

Phrase: "Haplotype patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "estimated by maximum-likelihood methods"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   827   C0024970:Maximum Likelihood Estimate [Intellectual Product,Quantitative Concept]
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0033204:Likelihood [Quantitative Concept]
   760   C0449851:Methods [Functional Concept]
   760   C0750572:Estimated [Quantitative Concept]
   760   C0806909:Maximum [Quantitative Concept]
   760   C1552615:maximum [Quantitative Concept]
   760   C2826546:MAXIMUM [Quantitative Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "(SNPHAP,"

Phrase: "www-gene.cimr.cam.ac.uk/clayton/software/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "haplotype frequency distributions"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   867   C0237580:Frequency Distribution [Quantitative Concept]
   827   C0037775:Distributions [Spatial Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   793 E C0520511:distribution [Idea or Concept]
   793 E C1704711:Distribution [Functional Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "compared by likelihood-ratio testing."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0150102:LIKELIHOOD RATIO [Quantitative Concept]
   760   C0033204:Likelihood [Quantitative Concept]
   760   C0039593:Testing [Functional Concept]
   760   C0392366:testing [Intellectual Product]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.130: Significance was determined by permutation (10,000 replicates). 

Phrase: "Significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined by permutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882348:Permutation [Qualitative Concept]

Phrase: "(10,000"

Phrase: "replicates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.131: Measures of linkage disequilibrium between SNPs were derived using the PM (Permutation and Model-free Analysis) program (25). 

Phrase: "Measures of linkage disequilibrium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0079809:Measures [Quantitative Concept]
   770   C1879489:Measures [Functional Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "between SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the PM (Permutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882348:Permutation [Qualitative Concept]

Phrase: "and"

Phrase: "Model-free Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: ")"

Phrase: "program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.132: To assess the evidence for linkage partitioning (1821), two complementary approaches were adopted. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the evidence for linkage partitioning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "(1821"

Phrase: ")"

Phrase: ","

Phrase: "two complementary approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]

Phrase: "were"

Phrase: "adopted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:Adopted [Finding]
Processing 00000000.tx.133: First, W2P probands were subdivided into "linked" (positive family NPL score at IDE) and "unlinked," and variant frequency comparisons were repeated. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "W2P probands"

Phrase: "were"

Phrase: "subdivided into """

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: """"

Phrase: "(positive family NPL score at IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449820:Score [Quantitative Concept]

Phrase: ")"

Phrase: "and """

Phrase: "unlinked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1548448:UNLINK [Intellectual Product]

Phrase: ","

Phrase: """"

Phrase: "and"

Phrase: "variant frequency comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "repeated."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.134: Second, the evidence for linkage at 10q was recomputed (using GENEHUNTER-PLUS [1]) after conditioning on the probands IDE genotype. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "at 10q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520266:10q [Nucleotide Sequence]

Phrase: "was"

Phrase: "recomputed"

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GENEHUNTER-PLUS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332287:Plus [Qualitative Concept]

Phrase: "[1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "]"

Phrase: ")"

Phrase: "after conditioning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009647:Conditioning [Mental Process]

Phrase: "on the probands IDE genotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0017431:Genotype [Organism Attribute]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
Processing 00000000.tx.135: The significance of changes in the linkage statistic was determined by permutation (10,000 replicates). 

Phrase: "The significance of changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "in the linkage statistic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2348149:Statistic [Quantitative Concept]
   861   C2828391:Statistic [Quantitative Concept]
   789 E C0038215:Statistical [Occupation or Discipline]

Phrase: "was"

Phrase: "determined by permutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882348:Permutation [Qualitative Concept]

Phrase: "(10,000"

Phrase: "replicates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.136: The power calculations described assume, for simplicity, that all cases are ascertained from affected sibpairs (to incorporate the ascertainment selection) and that all control samples are population based.  

Phrase: "The power calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1441506:Calculation [Activity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "assume"

Phrase: ","

Phrase: "for simplicity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205352:Simple [Qualitative Concept]

Phrase: "that"

Phrase: "all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "ascertained from affected sibpairs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "incorporate"

Phrase: "the ascertainment selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "all control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "are"

Phrase: "population based."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
   861   C1527178:Based [Functional Concept]
   861   C1705938:Based [Idea or Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C0178499:Base [Chemical Viewed Functionally]
   827 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.137: ACKNOWLEDGMENTS  This work was supported by Diabetes U.K. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Diabetes U.K."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1521721:Supported [Conceptual Entity]
   760   C1708601:K' [Quantitative Concept]
   726 E C0183683:Support [Medical Device]
Processing 00000000.tx.138: (which also supported ascertainment of many of the samples collected), the European Union (GIFT consortium, QLG2-CT-1999-00546), and the South and West National Health Service Research Directorate. 

Phrase: "("

Phrase: "which also supported ascertainment of many of the samples"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "the European Union"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015179:European Union [Organization]
   861   C0239307:European [Population Group]
   861   C1535514:European [Population Group]
   861   C2825217:Union [Classification]

Phrase: "(GIFT consortium,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1513822:Consortium [Professional or Occupational Group]
   861   C1880171:Consortium [Professional or Occupational Group]

Phrase: "QLG2-CT-1999-00546"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3540513:CT [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the South"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710133:South [Spatial Concept]

Phrase: "and"

Phrase: "West National Health Service Research Directorate."
Processing 00000000.tx.139: T.M.F. is a career scientist of the South and West National Health Service Research Directorate, K.R.O. is a Diabetes U.K. 

Phrase: "T.M.F."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1306057:M-F [Temporal Concept]
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "is"

Phrase: "a career scientist of the South"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0402112:Scientist [Professional or Occupational Group]

Phrase: "and"

Phrase: "West National Health Service Research Directorate,"

Phrase: "K.R.O."

Phrase: "is"

Phrase: "a Diabetes U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.140: Clinical Training Fellow, and A.T.H. is a Wellcome Trust Career Leave Research Fellow. 

Phrase: "Clinical Training Fellow,"

Phrase: "and"

Phrase: "A.T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   734   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a Wellcome Trust Career"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178534:career [Occupational Activity]

Phrase: "Leave"

Phrase: "Research Fellow."
Processing 00000000.tx.141: We thank all those who participated in these collections, and the many health professionals who contributed. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "all those"

Phrase: "who"

Phrase: "participated in these collections,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0600644:Collections [Intellectual Product]
   770   C1516698:Collection [Functional Concept]
   770   C1704814:Collection [Idea or Concept]

Phrase: "and"

Phrase: "the many health professionals"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018724:health professionals [Professional or Occupational Group]
  1000   C1704312:Health professionals [Professional or Occupational Group]
   861   C0679924:professionals [Professional or Occupational Group]
   827 E C2698884:Professional [Occupation or Discipline]

Phrase: "who"

Phrase: "contributed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]
Processing 00000000.tx.142: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.143: Sian Ellard for laboratory organization and Diane Jarvis for DNA extraction; 

Phrase: "Sian Ellard for laboratory organization"

Phrase: "and"

Phrase: "Diane Jarvis for DNA extraction"

Phrase: ";"
Processing 00000000.tx.144: Dr. 

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.145: Lesley Jones (Cardiff) for sharing IDE variant data; 

Phrase: "Lesley Jones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "(Cardiff"

Phrase: ")"

Phrase: "for sharing IDE variant data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1511726:Data [Idea or Concept]
   799   C3245479:data [Medical Device]

Phrase: ";"
Processing 00000000.tx.146: and Prof. 

Phrase: "and"

Phrase: "Prof."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599518:Prof. [Professional or Occupational Group]
Processing 00000000.tx.147: Paul Burton and colleagues (Leicester) for valuable statistical insights.  

Phrase: "Paul Burton"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(Leicester"

Phrase: ")"

Phrase: "for valuable statistical insights."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0233820:insights [Mental Process]
Processing 00000000.tx.148: FOOTNOTES  Address correspondence and reprint requests to Prof. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Prof."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0599518:Prof. [Professional or Occupational Group]
   790   C0686900:request [Functional Concept]
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
Processing 00000000.tx.149: Mark McCarthy, Robert Turner Professor of Diabetes, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Site, Old Road, Headington, Oxford OX3 7LJ, U.K. 

Phrase: "Mark McCarthy,"

Phrase: "Robert Turner Professor of Diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0599518:Professor [Professional or Occupational Group]

Phrase: "Oxford Centre for Diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "Endocrinology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   928 E C0694557:endocrinologic [Functional Concept]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Churchill Site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "Old Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Headington,"

Phrase: "Oxford OX3 7LJ,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.150: E-mail: mark.mccarthy{at}drl.ox.ac.uk . Received for publication 5 November 2002 and accepted in revised form 10 February 2003. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "mark.mccarthy{at}drl.ox.ac.uk ."

Phrase: "Received for publication 5 November 2002"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 10 February 2003."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.151: Additional information for this article can be found in an online appendix at http://diabetes.diabetesjournals.org. 

Phrase: "Additional information for this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1546922:Additional information [Temporal Concept]
   806   C1706499:ADDITIONAL INFORMATION [Intellectual Product]
   760   C1533716:Information [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "found in an online appendix"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003617:Appendix [Body Part, Organ, or Organ Component]
   760   C0150312:Found [Quantitative Concept]
   760   C1269000:Appendix [Body Part, Organ, or Organ Component]
   726 E C0243095:Find [Finding]

Phrase: "at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//diabetes.diabetesjournals.org."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]
Processing 00000000.tx.152: CON, control; 

Phrase: "CON,"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.153: DIF, Diabetes in Families Study; 

Phrase: "DIF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: ","

Phrase: "Diabetes in Families Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.154: ECACC, European Collection of Cell Cultures; 

Phrase: "ECACC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0598080:cell culture collection [Intellectual Product]
   760   C1516698:Collection [Functional Concept]
   760   C1704814:Collection [Idea or Concept]

Phrase: "European Collection of Cell Cultures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0598080:cell culture collection [Intellectual Product]
   760   C1516698:Collection [Functional Concept]
   760   C1704814:Collection [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.155: HAP, haplotype; 

Phrase: "HAP,"

Phrase: "haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.156: IDE, insulin-degrading enzyme; 

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.157: LOD, logarithm of odds; 

Phrase: "LOD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986775:Logarithm [Occupational Activity]

Phrase: "logarithm of odds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986775:Logarithm [Occupational Activity]

Phrase: ";"
Processing 00000000.tx.158: NCBI, National Center for Biotechnology Information; 

Phrase: "NCBI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0995203:NCBI [Intellectual Product]
  1000   C1705803:NCBI [Organization]

Phrase: "National Center for Biotechnology Information"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1705803:National Center for Biotechnology Information [Organization]
   875   C0021415:center information [Manufactured Object,Organization]
   804   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   804   C0205099:Center [Spatial Concept]
   804   C1533716:Information [Idea or Concept]
   804   C3245503:national [Intellectual Product]
   733 E C3242430:informational [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.159: NPL, nonparametric linkage; 

Phrase: "NPL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023745:linkage [Molecular Function]

Phrase: "nonparametric linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023745:linkage [Molecular Function]

Phrase: ";"
Processing 00000000.tx.160: OR, odds ratio; 

Phrase: "OR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.161: SNP, single nucleotide polymorphism; 

Phrase: "SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "single nucleotide polymorphism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.162: UTR, untranslated region; 

Phrase: "UTR,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "untranslated region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.163: W2P, Warren 2 probands; 

Phrase: "W2P,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1948021:Proband [Family Group]
   771 E C0702110:Propositus [Organism Attribute]
   743 E C0702111:probands [Organism Attribute]

Phrase: "Warren 2 probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0702111:probands [Organism Attribute]
   793 E C1948021:Proband [Family Group]
   755 E C0702110:Propositus [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.164: W2T, Warren 2 trios; 

Phrase: "W2T,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1336674:TRIO [Gene or Genome]
   793   C1448979:TRIO [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Warren 2 trios"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1336674:TRIO [Gene or Genome]
   793   C1448979:TRIO [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.165: YT2D, young type 2 diabetes.  

Phrase: "YT2D,"

Phrase: "young type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0011860:Type 2 Diabetes [Disease or Syndrome]
   875   C1320657:type diabetes [Finding]
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.166: REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS REFERENCES  Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M, ORahilly S, Frayling TM, Bell JI, Lathrop GM, Bennett A, Dhillon R, Fletcher C, Groves CJ, Jones E, Prestwich P, Simecek N, Subba Rao PV, Wishart M, Foxon R, Howell S, Smedley D, Cardon LR, Menzel S, McCarthy MI: A genome-wide scan for loci predisposing to type 2 diabetes in a U.K. population (The Diabetes (U.K.) Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Wiltshire S,"

Phrase: "Hattersley AT,"

Phrase: "Hitman GA,"

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Levy JC,"

Phrase: "Sampson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "ORahilly S,"

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Bell JI,"

Phrase: "Lathrop GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Bennett A,"

Phrase: "Dhillon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Fletcher C,"

Phrase: "Groves CJ,"

Phrase: "Jones E,"

Phrase: "Prestwich P,"

Phrase: "Simecek N,"

Phrase: "Subba Rao PV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032463:PV [Neoplastic Process]

Phrase: "Wishart M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Foxon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Howell S,"

Phrase: "Smedley D,"

Phrase: "Cardon LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Menzel S,"

Phrase: "McCarthy MI"

Phrase: ":"

Phrase: "A genome-wide scan for loci"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1517519:Genome Scan [Molecular Biology Research Technique]
   753   C0017428:Genome [Gene or Genome]
   753   C0034606:Scan [Diagnostic Procedure]
   753   C0332464:Wide [Spatial Concept]
   753   C0441633:Scan [Diagnostic Procedure]
   753   C2338314:Genome [Conceptual Entity]
   753   C2826292:SCAN [Finding]

Phrase: "predisposing to type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0231203:predisposing [Functional Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "in a U.K. population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "("

Phrase: "The Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "Warren 2 Repository"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872261:Repository [Manufactured Object]

Phrase: ")"

Phrase: ":"

Phrase: "analysis of 573 pedigrees"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "independent replication of a susceptibility locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0598312:Replication [Genetic Function]
   753   C1883725:replication [Qualitative Concept]

Phrase: "on chromosome 1q."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327882:chromosome 1q [Nucleotide Sequence]
           1q
Processing 00000000.tx.167: Am J Hum Genet69 :553 569,2001[Medline] Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS,Mohlke KL, Silander K, Kohtamaki K, Chines P, Balow Jr J, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB, Rha D, Segal L, Shapiro S, Sharaf R, Shurtleff B, So A, Tannenbaum J, Te C, Tovar J, Unni A, Welch C, Whiten R, Witt A, Blaschak-Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Langer EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Eriksson J, Toivanen L, Vidgren G, Nylund SJ, Tuomilehto-Wolf E, Ross EH, Demirchyan E, Hagopian WA, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M: The Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus Genetics (FUSION) Study. 

Phrase: "Am"

Phrase: "J Hum Genet69"

Phrase: ":"

Phrase: "553 569,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ghosh S,"

Phrase: "Watanabe RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Valle TT,"

Phrase: "Hauser ER,"

Phrase: "Magnuson VL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0228339:VL [Body Part, Organ, or Organ Component]
   861   C1424729:VL [Gene or Genome]
   861   C1858854:VL [Disease or Syndrome]

Phrase: "Langefeld CD,"

Phrase: "Ally DS,Mohlke KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1366480:KL [Gene or Genome]
   812   C1416656:KL [Gene or Genome]

Phrase: "Silander K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kohtamaki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chines P,"

Phrase: "Balow Jr J,"

Phrase: "Birznieks G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Chang J,"

Phrase: "Eldridge W,"

Phrase: "Erdos MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Karanjawala ZE,"

Phrase: "Knapp JI,"

Phrase: "Kudelko K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Martin C,"

Phrase: "Morales-Mena A,"

Phrase: "Musick A,"

Phrase: "Musick T,"

Phrase: "Pfahl C,"

Phrase: "Porter R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rayman JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Rha D,"

Phrase: "Segal L,"

Phrase: "Shapiro S,"

Phrase: "Sharaf R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Shurtleff B,"

Phrase: "So"

Phrase: "A,"

Phrase: "Tannenbaum J,"

Phrase: "Te C,"

Phrase: "Tovar J,"

Phrase: "Unni A,"

Phrase: "Welch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: "C,"

Phrase: "Whiten"

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Witt A,"

Phrase: "Blaschak-Harvan J,"

Phrase: "Douglas JA,"

Phrase: "Duren WL,"

Phrase: "Epstein MP,"

Phrase: "Fingerlin TE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C1705540:TE [Conceptual Entity]

Phrase: "Kaleta HS,"

Phrase: "Langer EM,"

Phrase: "Li C,"

Phrase: "McEachin RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Stringham HM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0262500:hm [Health Care Activity]
   861   C1512358:HM [Geographic Area]
   861   C3538713:HM [Idea or Concept]

Phrase: "Trager E,"

Phrase: "White PP,"

Phrase: "Eriksson J,"

Phrase: "Toivanen L,"

Phrase: "Vidgren G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Nylund SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Tuomilehto-Wolf E,"

Phrase: "Ross EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Demirchyan E,"

Phrase: "Hagopian WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Buchanan TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Tuomilehto J,"

Phrase: "Bergman RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Collins FS,"

Phrase: "Boehnke M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "The Finland-United States Investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C1261322:Investigation [Health Care Activity]
   812   C1552578:investigation [Idea or Concept]
   741 E C1517586:Investigational [Qualitative Concept]
   741 E C3245491:investigational [Intellectual Product]

Phrase: "of Non-Insulin-Dependent Diabetes Mellitus Genetics"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0596425:diabetes mellitus genetics [Occupation or Discipline]
   799   C0017398:Genetics [Biomedical Occupation or Discipline]
   799   C0017399:genetics [Biologic Function]
   780   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   780   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   734   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]

Phrase: "(FUSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332466:Fusion [Functional Concept]
  1000   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.168: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.169: An autosomal genome scan for genes that predispose to type 2 diabetes. 

Phrase: "An autosomal genome scan for genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1517519:Genome Scan [Molecular Biology Research Technique]
   753   C0017428:Genome [Gene or Genome]
   753   C0034606:Scan [Diagnostic Procedure]
   753   C0441633:Scan [Diagnostic Procedure]
   753   C2338314:Genome [Conceptual Entity]
   753   C2826292:SCAN [Finding]

Phrase: "that"

Phrase: "predispose to type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.170: Am J Hum Genet67 :1174 1185,2000[Medline] Meigs JB, Panhuysen CI, Myers RH, Wilson PW, Cupples LA: A genome-wide scan for loci linked to plasma levels of glucose and HbA1c in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study. 

Phrase: "Am"

Phrase: "J Hum Genet67"

Phrase: ":"

Phrase: "1174 1185,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Meigs JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Panhuysen CI,"

Phrase: "Myers RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Wilson PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Cupples LA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: ":"

Phrase: "A genome-wide scan for loci"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1517519:Genome Scan [Molecular Biology Research Technique]
   753   C0017428:Genome [Gene or Genome]
   753   C0034606:Scan [Diagnostic Procedure]
   753   C0332464:Wide [Spatial Concept]
   753   C0441633:Scan [Diagnostic Procedure]
   753   C2338314:Genome [Conceptual Entity]
   753   C2826292:SCAN [Finding]

Phrase: "linked to plasma levels of glucose"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   814   C0455280:glucose levels plasma [Laboratory or Test Result]
           glucose plasma
   783   C0202042:Plasma glucose [Laboratory Procedure]
   783   C0428548:glucose levels [Laboratory or Test Result]
   767 E C0337438:glucose level [Laboratory Procedure]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   719 E C0456079:Level [Classification]
   719   C1517892:Link [Intellectual Product]
   719 E C1547707:Level [Geographic Area]
   719   C1704666:Link [Intellectual Product]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "HbA1c in a community-based sample of Caucasian pedigrees"

Phrase: ":"

Phrase: "the Framingham Offspring Study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0557651:Study [Manufactured Object]
   827   C0680063:Offspring [Family Group]
   827   C2603343:Study [Research Activity]
   827   C3166866:Framingham [Intellectual Product]
Processing 00000000.tx.171: Diabetes51 :833 840,2002[Abstract/Free FullText] Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, OConnell P, Stern MP: Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "833 840,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duggirala R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Blangero J,"

Phrase: "Almasy L,"

Phrase: "Dyer TD,"

Phrase: "Williams KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Leach"

Phrase: "RJ,"

Phrase: "OConnell P,"

Phrase: "Stern MP"

Phrase: ":"

Phrase: "Linkage of type 2 diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0023745:linkage [Molecular Function]
   716   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
   716   C2984301:Type II diabetes mellitus [Functional Concept]

Phrase: "and of age at onset"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "to a genetic location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "on chromosome 10q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520266:10q [Nucleotide Sequence]

Phrase: "in Mexican Americans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025884:Mexican Americans [Population Group]
   861   C0596070:americans [Population Group]
Processing 00000000.tx.172: Am J Hum Genet64 :1127 1140,1999[Medline] Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Leptre F, Lecouer C, Gallina P, Zekiri L, Dina C, Froguel P: Genomewide search for type 2 diabetes-susceptibility genes in French Whites: evidence for a novel susceptibility locus for early onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21q24. 

Phrase: "Am"

Phrase: "J Hum Genet64"

Phrase: ":"

Phrase: "1127 1140,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vionnet N,"

Phrase: "Hani EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Dupont S,"

Phrase: "Gallina S,"

Phrase: "Francke S,"

Phrase: "Dotte S,"

Phrase: "De Matos F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Durand E,"

Phrase: "Leptre F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lecouer C,"

Phrase: "Gallina P,"

Phrase: "Zekiri L,"

Phrase: "Dina C,"

Phrase: "Froguel P"

Phrase: ":"

Phrase: "Genomewide search for type 2 diabetes-susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1552603:search [Intellectual Product]
   744   C1706202:Search [Activity]

Phrase: "in French Whites"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007457:Whites [Population Group]
   861   C0043157:Whites [Population Group]
   827 E C0220938:White [Qualitative Concept]

Phrase: ":"

Phrase: "evidence for a novel susceptibility locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "for early onset diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1833334:Early-onset [Finding]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "on chromosome 3q27-qter"

Phrase: "and"

Phrase: "independent replication of a type 2-diabetes locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0598312:Replication [Genetic Function]
   744   C1883725:replication [Qualitative Concept]

Phrase: "on chromosome 1q21q24."
Processing 00000000.tx.173: Am J Hum Genet67 :1470 1480,2000[Medline] Galli J, Li LS, Glaser A, stenson CG, Jiao H, Fakhrai-Rad H, Jacob HJ, Lander ES, Luthman H: Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. 

Phrase: "Am"

Phrase: "J Hum Genet67"

Phrase: ":"

Phrase: "1470 1480,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Galli J,"

Phrase: "Li LS,"

Phrase: "Glaser A,"

Phrase: "stenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Jiao H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Jacob HJ,"

Phrase: "Lander ES,"

Phrase: "Luthman H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Genetic analysis of non-insulin dependent diabetes mellitus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: "in the GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.174: Nat Genet12 :31 37,1996[Medline] Gauguier D, Froguel P, Parent V, Bernard C, Bihoreau MT, Portha B, James MR, Penicaud L, Lathrop M, Ktorza A: Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. 

Phrase: "Nat Genet12"

Phrase: ":"

Phrase: "31 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gauguier D,"

Phrase: "Froguel P,"

Phrase: "Parent V,"

Phrase: "Bernard C,"

Phrase: "Bihoreau MT,"

Phrase: "Portha B,"

Phrase: "James MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Penicaud L,"

Phrase: "Lathrop M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ktorza A"

Phrase: ":"

Phrase: "Chromosomal mapping of genetic loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
           Chromosome Mapping
   760   C1283195:Mapping [Activity]

Phrase: "associated with non-insulin dependent diabetes"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   882   C0011860:Non-Insulin Dependent Diabetes [Disease or Syndrome]
   833   C0011854:Insulin Dependent Diabetes [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1518422:Non [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.175: Nat Genet12 :38 43,1996[Medline] Galli J, Fakhrai-Rad H, Kamel A, Marcus C, Norgren S, Luthman H: Pathophysiological and genetic characterization of the major diabetes locus in GK rats. 

Phrase: "Nat Genet12"

Phrase: ":"

Phrase: "38 43,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Galli J,"

Phrase: "Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Kamel A,"

Phrase: "Marcus C,"

Phrase: "Norgren S,"

Phrase: "Luthman H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Pathophysiological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0031847:pathophysiology [Functional Concept]
   928   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "and"

Phrase: "genetic characterization of the major diabetes locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "in GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.176: Diabetes48 :2463 2470,1999[Abstract] Kaisaki PJ, Rouard M, Danoy PA, Wallis RH, Collins SC, Rice M, Levy ER, Lathrop M, Bihoreau MT, Gauguier D: Detailed comparative gene map of rat chromosome 1 with mouse and human genomes and physical mapping of an evolutionary chromosomal breakpoint. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "2463 2470,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kaisaki PJ,"

Phrase: "Rouard M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Danoy PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Wallis RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Collins SC,"

Phrase: "Rice M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Levy ER,"

Phrase: "Lathrop M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bihoreau MT,"

Phrase: "Gauguier D"

Phrase: ":"

Phrase: "Detailed comparative gene map of rat chromosome 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0814036:chromosome map [Intellectual Product]
   767   C1424473:MAP-1 [Gene or Genome]
   744   C0024779:Map [Manufactured Object]
   744   C1706473:Map [Conceptual Entity]

Phrase: "with mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human genomes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0017429:Human Genomes [Gene or Genome]
   861   C0017428:Genomes [Gene or Genome]
   827 E C2338314:Genome [Conceptual Entity]

Phrase: "and"

Phrase: "physical mapping of an evolutionary chromosomal breakpoint."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0599777:physical mapping [Laboratory Procedure,Molecular Biology Research Technique]
   776   C0600504:Physical Chromosome Mapping [Molecular Biology Research Technique]
   748   C1283195:Mapping [Activity]
   738   C0008630:Chromosome Mapping [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.177: Genomics64 :32 43,2000[Medline] Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernstrm M, Zierath JR, Norgren S, Luthman H, Galli J: Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. 

Phrase: "Genomics64"

Phrase: ":"

Phrase: "32 43,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Nikoshkov A,"

Phrase: "Kamel A,"

Phrase: "Fernstrm M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zierath JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Norgren S,"

Phrase: "Luthman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Galli J"

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "identified as a candidate diabetes susceptibility gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0919453:Susceptibility Gene [Gene or Genome]
   774   C1332838:Candidate Gene [Gene or Genome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0017337:Gene [Gene or Genome]
   748   C0205396:Identified [Qualitative Concept]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "in GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.178: Hum Mol Genet9 :2149 2158,2000[Abstract/Free FullText] Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: progress and potential. 

Phrase: "Hum Mol Genet9"

Phrase: ":"

Phrase: "2149 2158,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.179: Endocr Rev19 :608 624,1998[Abstract/Free FullText] Kurochkin IV: Insulin-degrading enzyme: embarking on amyloid destruction. 

Phrase: "Endocr Rev19"

Phrase: ":"

Phrase: "608 624,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kurochkin IV"

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "embarking on amyloid destruction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1261381:Destruction [Therapeutic or Preventive Procedure]
   770   C1948029:Destruction [Activity]
Processing 00000000.tx.180: Trends Biochem Sci26 :421 425,2001[Medline] Authier F, Posner BI, Bergeron JJM: Insulin-degrading enzyme. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem Sci26"

Phrase: ":"

Phrase: "421 425,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM"

Phrase: ":"

Phrase: "Insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.181: Clin Invest Med19 :149 160,1996[Medline] Seta KA, Roth RA: Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signalling. 

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "Med19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537680:MED19 [Gene or Genome]

Phrase: ":"

Phrase: "149 160,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seta KA,"

Phrase: "Roth RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Overexpression of insulin degrading enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: ":"

Phrase: "cellular localization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1660642:cellular localisation [Cell Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "effects on insulin signalling."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.182: Biochem Biophys Res Commun231 :167 171,1997[Medline] Jones CN, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM: Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. 

Phrase: "Biochem Biophys Res Commun231"

Phrase: ":"

Phrase: "167 171,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jones CN,"

Phrase: "Pei D,"

Phrase: "Staris P,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Chen YD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439205:yd [Quantitative Concept]

Phrase: "Reaven GM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: ":"

Phrase: "Alterations in the glucose-stimulated insulin secretory dose-response curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1515926:Alteration [Idea or Concept]

Phrase: "and in insulin clearance"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C1515981:And [Idea or Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2825073:Clearance [Natural Phenomenon or Process]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in nondiabetic insulin-resistant individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]
Processing 00000000.tx.183: J Clin Endocrinol Metab82 :1834 1838,1997[Abstract/Free FullText] Misbin RI, Almira EC, Cleman MW: Insulin degradation in serum of a patient with apparent insulin resistance. 

Phrase: "J Clin Endocrinol Metab82"

Phrase: ":"

Phrase: "1834 1838,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Misbin RI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035487:RI [Geographic Area]

Phrase: "Almira EC,"

Phrase: "Cleman MW"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin degradation in serum of a patient"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "with apparent insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.184: J Clin Endocrinol Metab52 :177 180,1981[Abstract] Abraham R, Myers A, DeVrieze FW, Hamshere MV, Thomas HM, Marshall H, Compton D, Spurlock G, Turic D, Hoogendoorn B, Kwon JM, Petersen RC, Tangalos E, Norton J, Morris JC, Bullock R, Liolitsa D, Lovestone S, Hardy J, Goate A, ODonovan M, Williams J, Owen MJ, Jones L: Substantial linkage disequilibrium across the insulin degrading enzyme locus but no association with late-onset Alzheimers disease. 

Phrase: "J Clin Endocrinol Metab52"

Phrase: ":"

Phrase: "177 180,"

Phrase: "1981"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Abraham R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Myers A,"

Phrase: "DeVrieze FW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332292:FW [Functional Concept]
   861   C2986896:FW [Idea or Concept]

Phrase: "Hamshere MV,"

Phrase: "Thomas HM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0262500:hm [Health Care Activity]
   861   C1512358:HM [Geographic Area]
   861   C3538713:HM [Idea or Concept]

Phrase: "Marshall H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Compton D,"

Phrase: "Spurlock G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Turic D,"

Phrase: "Hoogendoorn B,"

Phrase: "Kwon JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Petersen RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Tangalos E,"

Phrase: "Norton J,"

Phrase: "Morris JC,"

Phrase: "Bullock R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Liolitsa D,"

Phrase: "Lovestone S,"

Phrase: "Hardy J,"

Phrase: "Goate A,"

Phrase: "ODonovan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Williams J,"

Phrase: "Owen MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Jones L"

Phrase: ":"

Phrase: "Substantial linkage disequilibrium across the insulin degrading enzyme locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0023746:Linkage Disequilibrium [Quantitative Concept]
   742   C0023745:linkage [Molecular Function]
   742   C0281825:Disequilibrium [Finding]
   742   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "but"

Phrase: "no association with late-onset Alzheimers disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1511978:Disease Association [Temporal Concept]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
Processing 00000000.tx.185: Hum Genet109 :646 652,2001[Medline] Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TM, Mashima H, Schwarz PEH, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. 

Phrase: "Hum Genet109"

Phrase: ":"

Phrase: "646 652,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horikawa Y,"

Phrase: "Oda N,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Li X,"

Phrase: "Orho-Melander M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Hara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hinokio Y,"

Phrase: "Lindner TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Mashima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schwarz PEH,"

Phrase: "del Bosque-Plata L,"

Phrase: "Horikawa Y,"

Phrase: "Oda Y,"

Phrase: "Yoshiuchi I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Colilla S,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Wei S,"

Phrase: "Concannon P,"

Phrase: "Iwasaki N,"

Phrase: "Schulze J,"

Phrase: "Baier LJ,"

Phrase: "Bogardus C,"

Phrase: "Groop L,"

Phrase: "Boerwinkle E,"

Phrase: "Hanis CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Bell GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Genetic variation in the gene encoding calpain-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0042333:Genetic Variation [Natural Phenomenon or Process]
   744   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with type 2 diabetes mellitus."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   882   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   882   C2984301:Type II diabetes mellitus [Functional Concept]
   790   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.186: Nat Genet26 :163 175,2000[Medline] Sun L, Cox NJ, McPeek MS: A statistical method for identification of polymorphisms that explain a linkage results. 

Phrase: "Nat Genet26"

Phrase: ":"

Phrase: "163 175,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sun L,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "McPeek MS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: ":"

Phrase: "A statistical method for identification of polymorphisms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C1301921:Method of identification [Qualitative Concept]
   778   C1710191:Statistical Method [Research Activity]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "explain"

Phrase: "a linkage results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.187: Am J Hum Genet70 :399 411,2002[Medline] Li C, Scott LJ, Boehnke M: Allele-sharing linkage analysis on subsets of families stratified based on an associated allele (Abstract). 

Phrase: "Am"

Phrase: "J Hum Genet70"

Phrase: ":"

Phrase: "399 411,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li C,"

Phrase: "Scott LJ,"

Phrase: "Boehnke M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Allele-sharing linkage analysis on subsets of families"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0796345:linkage analysis [Laboratory Procedure]
   750   C2986480:Subset Analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0023745:linkage [Molecular Function]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "stratified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205363:Stratified [Qualitative Concept]

Phrase: "based on an associated allele"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0002085:Allele [Gene or Genome]
   760   C0332281:Associated [Qualitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.188: Am J Hum Genet71 (Suppl.) 

Phrase: "Am"

Phrase: "J Hum Genet71"

Phrase: "(Suppl."

Phrase: ")"
Processing 00000000.tx.189: :574 ,2002 Farook VS, Hanson RL, Wolford JK, Bogardus C, Prochazka M: Molecular analysis of KCNJ10 on 1q as a candidate gene for type 2 diabetes in Pima Indians. 

Phrase: ":"

Phrase: "574 ,"

Phrase: "2002 Farook"

Phrase: "VS"

Phrase: ","

Phrase: "Hanson RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Wolford JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Bogardus C,"

Phrase: "Prochazka M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Molecular analysis of KCNJ10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1513380:Molecular Analysis [Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "on 1q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327882:1q [Nucleotide Sequence]

Phrase: "as a candidate gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332838:Candidate Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "for type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in Pima Indians."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C1551488:Pima Indian [Population Group]
           Pima
   861   C1524069:Indians [Population Group]
   805 E C0032831:Potassium Iodide [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.190: Diabetes51 :3342 3346,2002[Abstract/Free FullText] Frayling TM, Walker M, McCarthy MI, Evans JC, Ayres S, Allen LI, Ellard S, Lynn S, Turner RC, ORahilly S, Hitman GA, Hattersley AT: Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "3342 3346,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "McCarthy MI,"

Phrase: "Evans JC,"

Phrase: "Ayres S,"

Phrase: "Allen LI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Ellard S,"

Phrase: "Lynn S,"

Phrase: "Turner RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "ORahilly S,"

Phrase: "Hitman GA,"

Phrase: "Hattersley AT"

Phrase: ":"

Phrase: "Parent-offspring trios"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1336674:TRIO [Gene or Genome]
   793   C1448979:TRIO [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "a resource to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035201:Resource [Idea or Concept]

Phrase: "facilitate"

Phrase: "the identification of type 2 diabetes genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.191: Diabetes48 :2475 2479,1999[Abstract] Minton J, Hattersley AT, Owen KR, McCarthy MI, Walker M, Barrett T, Frayling TM: Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "2475 2479,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Minton J,"

Phrase: "Hattersley AT,"

Phrase: "Owen KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "McCarthy MI,"

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Barrett T,"

Phrase: "Frayling TM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: ":"

Phrase: "Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "studies of genetic variation"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   833   C0042333:Genetic Variation [Natural Phenomenon or Process]
   819   C2827447:Genetic Study [Research Activity]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0205419:Variation [Qualitative Concept]
   770   C0314603:Genetic [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "in the WFS1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1421501:WFS1 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "type 2 diabetes in U.K. populations."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0011860:Type 2 Diabetes [Disease or Syndrome]
   778   C0441730:Type 2 [Classification]
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.192: Diabetes51 :1287 1290,2002[Abstract/Free FullText] Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "1287 1290,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gabriel SB,"

Phrase: "Schaffner SF,"

Phrase: "Nguyen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Moore JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Roy J,"

Phrase: "Blumenstiel B,"

Phrase: "Higgins J,"

Phrase: "DeFelice M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lochner A,"

Phrase: "Faggart M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Liu-Cordero SN,"

Phrase: "Rotimi C,"

Phrase: "Adeyemo A,"

Phrase: "Cooper R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ward R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lander ES,"

Phrase: "Daly MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Altshuler D"

Phrase: ":"

Phrase: "The structure of haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:Structure [Spatial Concept]

Phrase: "blocks in the human genome."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0017429:Genome, Human [Gene or Genome]
   760   C0017428:Genome [Gene or Genome]
   760   C0028778:Block [Pathologic Function]
   760   C0086418:Human [Human]
   760   C0332206:Block [Functional Concept]
   760   C1533157:Block [Substance]
   760   C1706084:Block [Geographic Area]
   760   C2338314:Genome [Conceptual Entity]
   760   C2828370:Block [Quantitative Concept]
Processing 00000000.tx.193: Science296 :2225 2229,2002[Abstract/Free FullText] Zhao JH, Curtis D, Sham PC: Model-free analysis and permutation test for allelic association. 

Phrase: "Science296"

Phrase: ":"

Phrase: "2225 2229,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhao JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Curtis D,"

Phrase: "Sham PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "Model-free analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "permutation test for allelic association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0017381:Allelism Test [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
Processing 00000000.tx.194: Hum Hered50 :133 139,2000[Medline]

Phrase: "Hum Hered50"

Phrase: ":"

Phrase: "133 139,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

